BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol. 2012;56:671-685. [PMID: 22340672 DOI: 10.1016/j.jhep.2011.11.007] [Cited by in Crossref: 553] [Cited by in F6Publishing: 401] [Article Influence: 55.3] [Reference Citation Analysis]
Number Citing Articles
1 Tang N, Sandahl TD, Ott P, Kepp KP. Computing the Pathogenicity of Wilson's Disease ATP7B Mutations: Implications for Disease Prevalence. J Chem Inf Model 2019;59:5230-43. [PMID: 31751128 DOI: 10.1021/acs.jcim.9b00852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Aramendía M, Rello L, Resano M, Vanhaecke F. Isotopic analysis of Cu in serum samples for diagnosis of Wilson's disease: a pilot study. J Anal At Spectrom 2013;28:675. [DOI: 10.1039/c3ja30349g] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
3 Stankiewicz R, Patkowski W, Zieniewicz K. Diagnostic Dilemma and Treatment Outcome in Acute Liver Failure Due to Wilson's Disease. Ann Transplant 2021;26:e930146. [PMID: 34001844 DOI: 10.12659/AOT.930146] [Reference Citation Analysis]
4 Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: A review for clinicians. World J Hepatol 2021; 13(11): 1688-1698 [PMID: 34904038 DOI: 10.4254/wjh.v13.i11.1688] [Reference Citation Analysis]
5 Joshi D, Gupta N, Samyn M, Deheragoda M, Dobbels F, Heneghan MA. The management of childhood liver diseases in adulthood. Journal of Hepatology 2017;66:631-44. [DOI: 10.1016/j.jhep.2016.11.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
6 Yu XE, Pan M, Han YZ, Yang RM, Wang J, Gao S. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth 2019;19:522. [PMID: 31878905 DOI: 10.1186/s12884-019-2641-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, Bruha R, Houwen R, Pop TL, Stauber R, Gschwantler M, Pfeiffenberger J, Yurdaydin C, Aigner E, Steindl-Munda P, Dienes HP, Zoller H, Weiss KH. Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. Hepatology 2019;69:1464-76. [PMID: 30232804 DOI: 10.1002/hep.30280] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 22.0] [Reference Citation Analysis]
8 Stättermayer AF, Entenmann A, Gschwantler M, Zoller H, Hofer H, Ferenci P. The dilemma to diagnose Wilson disease by genetic testing alone. Eur J Clin Invest 2019;49:e13147. [PMID: 31169307 DOI: 10.1111/eci.13147] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
9 García-Cortés M, Ortega-Alonso A, Andrade RJ. Safety of treating acute liver injury and failure. Expert Opin Drug Saf 2021;:1-13. [PMID: 34254839 DOI: 10.1080/14740338.2021.1955854] [Reference Citation Analysis]
10 Dong Y, Wu ZY. Challenges and suggestions for precise diagnosis and treatment of Wilson's disease. World J Pediatr 2021;17:561-5. [PMID: 34714531 DOI: 10.1007/s12519-021-00475-4] [Reference Citation Analysis]
11 Qian Z, Cui X, Huang Y, Liu Y, Li N, Zheng S, Jiang J, Cui S. Novel mutations found in the ATP7B gene in Chinese patients with Wilson's disease. Mol Genet Genomic Med 2019;7:e649. [PMID: 30884209 DOI: 10.1002/mgg3.649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Trocello JM, El Balkhi S, Woimant F, Girardot-Tinant N, Chappuis P, Lloyd C, Poupon J. Relative exchangeable copper: a promising tool for family screening in Wilson disease. Mov Disord. 2014;29:558-562. [PMID: 24375554 DOI: 10.1002/mds.25763] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
13 Balashova MS, Tuluzanovskaya IG, Glotov OS, Glotov AS, Barbitoff YA, Fedyakov MA, Alaverdian DA, Ivashchenko TE, Romanova OV, Sarana AM, Scherbak SG, Baranov VS, Filimonov MI, Skalny AV, Zhuchenko NA, Ignatova TM, Asanov AY. The spectrum of pathogenic variants of the ATP7B gene in Wilson disease in the Russian Federation. J Trace Elem Med Biol 2020;59:126420. [PMID: 31708252 DOI: 10.1016/j.jtemb.2019.126420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Saracco GM, Evangelista A, Fagoonee S, Ciccone G, Bugianesi E, Caviglia GP, Abate ML, Rizzetto M, Pellicano R, Smedile A. Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014. World J Gastroenterol 2016; 22(36): 8187-8193 [PMID: 27688660 DOI: 10.3748/wjg.v22.i36.8187] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
15 Osterode W, Falkenberg G, Wrba F. Copper and Trace Elements in Gallbladder form Patients with Wilson's Disease Imaged and Determined by Synchrotron X-ray Fluorescence. J Imaging 2021;7:261. [PMID: 34940728 DOI: 10.3390/jimaging7120261] [Reference Citation Analysis]
16 Stremmel W, Merle U. Liver: A new copper cut-off value for diagnosis of Wilson disease? Nat Rev Gastroenterol Hepatol 2015;12:493-4. [PMID: 26260373 DOI: 10.1038/nrgastro.2015.132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Harada M, Honma Y, Yoshizumi T, Kumamoto K, Oe S, Harada N, Tanimoto A, Yabuki K, Karasuyama T, Yoneda A, Shibata M. Idiopathic copper toxicosis: is abnormal copper metabolism a primary cause of this disease? Med Mol Morphol 2020;53:50-5. [DOI: 10.1007/s00795-019-00227-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
18 Ranucci G, Socha P, Iorio R. Wilson disease: What is still unclear in pediatric patients? Clinics and Research in Hepatology and Gastroenterology 2014;38:268-72. [DOI: 10.1016/j.clinre.2014.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, Fonoff ET, Bor-Seng-Shu E, Machado AA, Schenck CH, Teixeira MJ, Barbosa ER. Wilson's disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med 2016;17:179-85. [PMID: 26763676 DOI: 10.1016/j.sleep.2015.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
20 Wang DW, Yin YM, Yao YM. Advances in the management of acute liver failure. World J Gastroenterol 2013; 19(41): 7069-7077 [PMID: 24222950 DOI: 10.3748/wjg.v19.i41.7069] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
21 Kim S, Song IU, Chung YA, Choi EK, Oh JK. Brain MRI, Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT Findings in a Patient with Wilson Disease: A Case Report. Nucl Med Mol Imaging 2014;48:303-5. [PMID: 26396635 DOI: 10.1007/s13139-014-0290-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Zhou ZH, Wu YF, Cao J, Hu JY, Han YZ, Hong MF, Wang GQ, Liu SH, Wang XM. Characteristics of neurological Wilson's disease with corpus callosum abnormalities. BMC Neurol 2019;19:85. [PMID: 31053106 DOI: 10.1186/s12883-019-1313-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol 2020;11:40-7. [PMID: 31885839 DOI: 10.1136/flgastro-2018-101139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
24 Członkowska A, Rodo M, Wierzchowska-Ciok A, Smolinski L, Litwin T. Accuracy of the radioactive copper incorporation test in the diagnosis of Wilson disease. Liver Int 2018;38:1860-6. [PMID: 29418065 DOI: 10.1111/liv.13715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Litwin T, Dusek P, Czlonkowska A. Neurological manifestations in Wilson’s disease –possible treatment options for symptoms. Expert Opinion on Orphan Drugs 2016;4:719-28. [DOI: 10.1080/21678707.2016.1188003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Tribl GG, Trindade MC, Schredl M, Pires J, Reinhard I, Bittencourt T, Lorenzi-Filho G, Alves RC, de Andrade DC, Fonoff ET, Bor-Seng-Shu E, Machado AA, Teixeira MJ, Barbosa ER. Dream Recall Frequencies and Dream Content in Wilson's Disease with and without REM Sleep Behaviour Disorder: A Neurooneirologic Study. Behav Neurol 2016;2016:2983205. [PMID: 27051076 DOI: 10.1155/2016/2983205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Yang X, Tang XP, Zhang YH, Luo KZ, Jiang YF, Luo HY, Lei JH, Wang WL, Li MM, Chen HC, Deng SL, Lai LY, Liang J, Zhang M, Tian Y, Xu Y. Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample. Hepatology 2015;62:1731-41. [PMID: 26095812 DOI: 10.1002/hep.27932] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
28 Pfister E, Karch A, Adam R, Polak WG, Karam V, Mirza D, O’grady J, Klempnauer J, Reding R, Kalicinski P, Coker A, Trunecka P, Astarcioglu I, Jacquemin E, Pratschke J, Paul A, Popescu I, Schneeberger S, Boillot O, Fischer L, Mikolajczyk RT, Baumann U, Duvoux C; for all European Liver Transplant Registry contributing centers and the European Liver Intestine Transplant Association. Predictive Factors for Survival in Children Receiving Liver Transplants for Wilson’s Disease: A Cohort Study Using European Liver Transplant Registry Data. Liver Transpl 2018;24:1186-98. [DOI: 10.1002/lt.25308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Solovyev N, Ala A, Schilsky M, Mills C, Willis K, Harrington CF. Biomedical copper speciation in relation to Wilson’s disease using strong anion exchange chromatography coupled to triple quadrupole inductively coupled plasma mass spectrometry. Analytica Chimica Acta 2020;1098:27-36. [DOI: 10.1016/j.aca.2019.11.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
30 Schilsky ML. Wilson Disease: Diagnosis, Treatment, and Follow-up. Clin Liver Dis. 2017;21:755-767. [PMID: 28987261 DOI: 10.1016/j.cld.2017.06.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 7.6] [Reference Citation Analysis]
31 Pfeiffenberger J, Mogler C, Gotthardt DN, Schulze-Bergkamen H, Litwin T, Reuner U, Hefter H, Huster D, Schemmer P, Członkowska A, Schirmacher P, Stremmel W, Cassiman D, Weiss KH. Hepatobiliary malignancies in Wilson disease. Liver Int 2015;35:1615-22. [PMID: 25369181 DOI: 10.1111/liv.12727] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
32 Wu F, Wang J, Pu C, Qiao L, Jiang C. Wilson's disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci. 2015;16:6419-6431. [PMID: 25803104 DOI: 10.3390/ijms16036419] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
33 Feng H, Fu Q, Du W, Zhu R, Ge X, Wang C, Li Q, Su L, Yang H, Song J. Quantitative Assessment of Copper(II) in Wilson's Disease Based on Photoacoustic Imaging and Ratiometric Surface-Enhanced Raman Scattering. ACS Nano 2021;15:3402-14. [PMID: 33508938 DOI: 10.1021/acsnano.0c10407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
34 Glavind E, Gotthardt DN, Pfeiffenberger J, Sandahl TD, Bashlekova T, Willemoe GL, Hasselby JP, Weiss KH, Møller HJ, Vilstrup H, Lee WM, Schilsky ML, Ott P, Grønbæk H. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Orphanet J Rare Dis 2020;15:173. [PMID: 32615997 DOI: 10.1186/s13023-020-01452-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Himoto T, Masaki T. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020;12:E2084. [PMID: 32674425 DOI: 10.3390/nu12072084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Roberts EA. “Not so rare” Wilson disease. Clinics and Research in Hepatology and Gastroenterology 2013;37:219-21. [DOI: 10.1016/j.clinre.2013.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Ivanova II, Kotzev IA, Atanassova MV, Gancheva DT, Pavlov SI, Krasnaliev IJ, Konstantinova DH. Wilson’s disease in association with anetoderma. Clin J Gastroenterol 2015;8:52-6. [DOI: 10.1007/s12328-015-0550-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
38 Koens LH, de Vries JJ, Vansenne F, de Koning TJ, Tijssen MAJ. How to detect late-onset inborn errors of metabolism in patients with movement disorders - A modern diagnostic approach. Parkinsonism Relat Disord 2021;85:124-32. [PMID: 33745796 DOI: 10.1016/j.parkreldis.2021.02.029] [Reference Citation Analysis]
39 Jing XZ, Yuan XZ, Li GY, Chen JL, Wu R, Yang LL, Zhang SY, Wang XP, Li JQ. Increased Magnetic Susceptibility in the Deep Gray Matter Nuclei of Wilson's Disease: Have We Been Ignoring Atrophy? Front Neurosci 2022;16:794375. [PMID: 35720701 DOI: 10.3389/fnins.2022.794375] [Reference Citation Analysis]
40 Gaur K, Vázquez-salgado A, Duran-camacho G, Dominguez-martinez I, Benjamín-rivera J, Fernández-vega L, Carmona Sarabia L, Cruz García A, Pérez-deliz F, Méndez Román J, Vega-cartagena M, Loza-rosas S, Rodriguez Acevedo X, Tinoco A. Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy. Inorganics 2018;6:126. [DOI: 10.3390/inorganics6040126] [Reference Citation Analysis]
41 Henriet T, Nicolaï B, Ghaddar C, Barrio M, Do B, Yagoubi N, Tamarit J, Rietveld IB. Triethylenetetramine Dihydrochloride: Interactions and Conformations in Two Anhydrous Structures and a Hydrate. Crystal Growth & Design 2015;15:348-57. [DOI: 10.1021/cg501444t] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
42 Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, Eberhagen C, Rieder T, Janik D, Neff F, Straub BK, Schirmacher P, DiSpirito AA, Bandow N, Baral BS, Flatley A, Kremmer E, Denk G, Reiter FP, Hohenester S, Eckardt-Schupp F, Dencher NA, Adamski J, Sauer V, Niemietz C, Schmidt HH, Merle U, Gotthardt DN, Kroemer G, Weiss KH, Zischka H. Methanobactin reverses acute liver failure in a rat model of Wilson disease. J Clin Invest 2016;126:2721-35. [PMID: 27322060 DOI: 10.1172/JCI85226] [Cited by in Crossref: 77] [Cited by in F6Publishing: 37] [Article Influence: 12.8] [Reference Citation Analysis]
43 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
44 Langwińska-Wośko E, Litwin T, Dzieżyc K, Karlinski M, Członkowska A. Optical coherence tomography as a marker of neurodegeneration in patients with Wilson's disease. Acta Neurol Belg 2017;117:867-71. [PMID: 28488258 DOI: 10.1007/s13760-017-0788-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
45 Sukezaki A, Chu PS, Shinoda M, Hibi T, Taniki N, Yoshida A, Kawaida M, Hori S, Morikawa R, Kurokouchi A, Wakino S, Kameyama K, Obara H, Kitagawa Y, Saito H, Kanai T, Nakamoto N. Late-onset acute liver failure due to Wilson's disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review. Clin J Gastroenterol 2020;13:1239-46. [PMID: 32643122 DOI: 10.1007/s12328-020-01175-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Ferrarese A, Morelli MC, Carrai P, Milana M, Angelico M, Perricone G, Belli LS, Marrone G, Grieco A, Martini S, Manini MA, Fagiuoli S, Toniutto P, Galeota Lanza A, Bhoori S, Petta S, Giannini EG, Burra P. Outcomes of Liver Transplant for Adults With Wilson's Disease. Liver Transpl 2020;26:507-16. [PMID: 31901209 DOI: 10.1002/lt.25714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, Weiss KH, Gauss A. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. [DOI: 10.1007/s10545-018-0218-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Ferenci P. Whom and how to screen for Wilson disease. Expert Rev Gastroenterol Hepatol. 2014;8:513-520. [PMID: 24650289 DOI: 10.1586/17474124.2014.899898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
49 Alakus MF, Caglayan M, Ekin N, Oncul H, Arac E, Dag U, Diri H. Investigation of corneal topographic and densitometric properties of Wilson's disease patients with or without a Kayser-Fleischer ring. Eye Vis (Lond) 2021;8:8. [PMID: 33706814 DOI: 10.1186/s40662-021-00231-9] [Reference Citation Analysis]
50 Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, Paziewska A, Dabrowska M, Mikula M, Kaminska D, Wiernicka A, Socha P, Czlonkowska A, Ostrowski J. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype. Liver Int 2019;39:177-86. [DOI: 10.1111/liv.13967] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
51 Yuan XZ, Yang RM, Wang XP. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol 2021;19:465-85. [PMID: 32351182 DOI: 10.2174/1570159X18666200429233517] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Pugliese M, Biondi V, Gugliandolo E, Licata P, Peritore AF, Crupi R, Passantino A. D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective. Antibiotics (Basel) 2021;10:648. [PMID: 34071639 DOI: 10.3390/antibiotics10060648] [Reference Citation Analysis]
53 Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31743430 DOI: 10.1002/14651858.CD012267.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Pigatto PD, Soldarini A, Guzzi G. Copper metabolism and green serum during pregnancy. Clin Biochem 2016;49:839-40. [PMID: 27143675 DOI: 10.1016/j.clinbiochem.2016.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Kalita J, Kumar V, Misra UK, Parashar V, Ranjan A. Adjunctive Antioxidant Therapy in Neurologic Wilson’s Disease Improves the Outcomes. J Mol Neurosci 2020;70:378-85. [DOI: 10.1007/s12031-019-01423-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Squitti R, Faller P, Hureau C, Granzotto A, White AR, Kepp KP. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology. J Alzheimers Dis 2021;83:23-41. [PMID: 34219710 DOI: 10.3233/JAD-201556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Orlando LA, Wu RR, Myers RA, Neuner J, McCarty C, Haller IV, Harry M, Fulda KG, Dimmock D, Rakhra-Burris T, Buchanan A, Ginsburg GS. At the intersection of precision medicine and population health: an implementation-effectiveness study of family health history based systematic risk assessment in primary care. BMC Health Serv Res 2020;20:1015. [PMID: 33160339 DOI: 10.1186/s12913-020-05868-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Russell K, Gillanders LK, Orr DW, Plank LD. Dietary copper restriction in Wilson's disease. Eur J Clin Nutr 2018;72:326-31. [PMID: 29235558 DOI: 10.1038/s41430-017-0002-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
59 El Imad T, Al Moussawi H, Haddad FG, Felix R, Mulrooney SM. Wilson's Disease: Expect the Unexpected. Cureus 2018;10:e2173. [PMID: 29644160 DOI: 10.7759/cureus.2173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Arai S, Kogiso T, Ogasawara Y, Sagawa T, Taniai M, Tokushige K. Long-term outcome of Wilson's disease complicated by liver disease. JGH Open 2021;5:793-800. [PMID: 34263074 DOI: 10.1002/jgh3.12589] [Reference Citation Analysis]
61 Hou Y, Lin J, Shang H. Brain Calcification in a Young Adult with Abnormal Copper Metabolism. Mov Disord Clin Pract 2021;8:476-9. [PMID: 33816683 DOI: 10.1002/mdc3.13145] [Reference Citation Analysis]
62 Munk DE, Björklund J, Lund Laursen T, Vilstrup H, Ott P, Grønbæk H, Damgaard Sandahl T. The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease. Scand J Gastroenterol 2022;:1-6. [PMID: 34994677 DOI: 10.1080/00365521.2021.2024248] [Reference Citation Analysis]
63 Ferenci P, Pfeiffenberger J, Stättermayer AF, Stauber RE, Willheim C, Weiss KH, Munda-Steindl P, Trauner M, Schilsky M, Zoller H. HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease. JHEP Rep 2019;1:2-8. [PMID: 32039348 DOI: 10.1016/j.jhepr.2019.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
64 Mak CM. Biochemical Diagnosis of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 237-48. [DOI: 10.1016/b978-0-12-810532-0.00021-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Feltracco P, Cagnin A, Carollo C, Barbieri S, Ori C. Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 2017;31:193-206. [DOI: 10.1016/j.trre.2017.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
66 Kim H, Park YN. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2014;28:813-29. [DOI: 10.1016/j.bpg.2014.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
67 Haftu H, Mustefa M, Gebrehiwot T. Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease? Case Reports Hepatol 2020;2020:1275940. [PMID: 32528738 DOI: 10.1155/2020/1275940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Svetel M, Božić M, Vitković J, Jovanović Č, Dragašević N, Pekmezović T, Svetel M, Tomić A, Kresojević N, Kostić V. Optical coherence tomography in patients with Wilson's disease. Acta Neurol Scand 2021;144:149-54. [PMID: 33881171 DOI: 10.1111/ane.13431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Collins CJ, Yi F, Dayuha R, Duong P, Horslen S, Camarata M, Coskun AK, Houwen RHJ, Pop TL, Zoller H, Yoo HW, Jung SW, Weiss KH, Schilsky ML, Ferenci P, Hahn SH. Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease. Gastroenterology 2021;160:2367-2382.e1. [PMID: 33640437 DOI: 10.1053/j.gastro.2021.02.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
70 Aaraj S, Khan SA, Ali N, Iqbal Malik MI, Dar FS. Wilson Disease in Children; Chelation Therapy or Liver Transplantation? A 10-Year Experience from Pakistan. Ann Transplant 2021;26:e932606. [PMID: 34608110 DOI: 10.12659/AOT.932606] [Reference Citation Analysis]
71 Lu CX, Qing Lin, Huang WQ, Tzeng CM. New mutations and polymorphisms of the ATP7B gene in sporadic Wilson disease. Eur J Med Genet. 2014;57:498-502. [PMID: 24878384 DOI: 10.1016/j.ejmg.2014.04.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
72 Hu X, Chen S, Huang CB, Qian Y, Yu Y. Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson's disease: a resting-state fMRI study. Metab Brain Dis 2017;32:685-92. [PMID: 28116563 DOI: 10.1007/s11011-016-9946-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
73 Liu L, Gong Q, Liu J, Shen H, Zhang H, Xue Y. Plasma transfusion combined with chelating therapy alleviates fulminant Wilson's disease with a single Arg778Leu heterozygote mutation. Ann Hepatol 2019;18:393-6. [PMID: 31010795 DOI: 10.1016/j.aohep.2018.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
74 Duncan A, Yacoubian C, Beetham R, Catchpole A, Bullock D. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease. Ann Clin Biochem. 2017;54:649-654. [PMID: 27742851 DOI: 10.1177/0004563216676843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
75 Dufernez F, Lachaux A, Chappuis P, De Lumley L, Bost M, Woimant F, Misrahi M, Debray D. Wilson disease in offspring of affected patients: Report of four French families. Clinics and Research in Hepatology and Gastroenterology 2013;37:240-5. [DOI: 10.1016/j.clinre.2013.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
76 Woimant F, Djebrani-Oussedik N, Poujois A. New tools for Wilson's disease diagnosis: exchangeable copper fraction. Ann Transl Med. 2019;7:S70. [PMID: 31179307 DOI: 10.21037/atm.2019.03.02] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
77 Hayashi H, Tatsumi Y, Yahata S, Hayashi H, Momose K, Isaji R, Sasaki Y, Hayashi K, Wakusawa S, Goto H. Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors. J Clin Transl Hepatol 2015;3:239-45. [PMID: 26807378 DOI: 10.14218/JCTH.2015.00032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
78 Pal A, Prasad R. An overview of various mammalian models to study chronic copper intoxication associated Alzheimer’s disease like pathology. Biometals 2015;28:1-9. [DOI: 10.1007/s10534-014-9799-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
79 Saracoglu S, Gumus K, Doganay S, Koc G, Kacar Bayram A, Arslan D, Gumus H. Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson's disease: evaluation with quantitative susceptibility mapping. Acta Radiol 2018;59:1380-5. [PMID: 29482344 DOI: 10.1177/0284185118759821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
80 Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease. Ann N Y Acad Sci. 2014;1315:1-5. [PMID: 24517292 DOI: 10.1111/nyas.12340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
81 Fernando M, van Mourik I, Wassmer E, Kelly D. Wilson disease in children and adolescents. Arch Dis Child 2020;105:499-505. [PMID: 31974298 DOI: 10.1136/archdischild-2018-315705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
82 Guttmann S, Nadzemova O, Grünewald I, Lenders M, Brand E, Zibert A, Schmidt HH. ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells. PLoS One 2020;15:e0230025. [PMID: 32155648 DOI: 10.1371/journal.pone.0230025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
83 Dhakal B, Prabhat K, Karki A, Bhattarai AM, Sapkota S, Subedi B, Dahal A. Late onset Wilson Disease with normal neuro-psychiatric status: A case report. Annals of Medicine and Surgery 2022;77:103678. [DOI: 10.1016/j.amsu.2022.103678] [Reference Citation Analysis]
84 Wang RM, Yu H, Yang GM, Xu WQ, Xia N, Zhang Y, Ni W, Dong Y, Wu ZY. Clinical features and outcome of Wilson's disease with generalized epilepsy in Chinese patients. CNS Neurosci Ther 2020;26:842-50. [PMID: 32281751 DOI: 10.1111/cns.13373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Oh JH, Goh MJ, Park Y, Kim J, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events. Dig Dis Sci 2021;66:2816-25. [PMID: 32897445 DOI: 10.1007/s10620-020-06591-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Llovet LP, Gratacós-Ginés J, Ortiz O, Rodriguez-Tajes S, Lens S, Reverter E, Ruiz-Ortiz E, Costa J, Viñas O, Forns X, Parés A, Londoño MC. Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies. Liver Int 2020;40:558-64. [PMID: 31863722 DOI: 10.1111/liv.14332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
87 Brandi G, Rizzo A, Deserti M, Relli V, Indio V, Bin S, Pariali M, Palloni A, De Lorenzo S, Tovoli F, Tavolari S. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster. BMC Med Genet 2020;21:225. [PMID: 33208122 DOI: 10.1186/s12881-020-01165-0] [Reference Citation Analysis]
88 Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin. 2015;33:175-204. [PMID: 25432729 DOI: 10.1016/j.ncl.2014.09.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
89 Lozano Herrero J, Muñoz Bertrán E, Ortega González I, Gómez Espín R, López Espín MI. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease. Gastroenterología y Hepatología 2012;35:704-7. [DOI: 10.1016/j.gastrohep.2012.03.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
90 Hefter H, Samadzadeh S. Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review. Toxins (Basel) 2021;13:241. [PMID: 33805281 DOI: 10.3390/toxins13040241] [Reference Citation Analysis]
91 Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features. Handb Clin Neurol 2017;142:101-19. [PMID: 28433096 DOI: 10.1016/B978-0-444-63625-6.00010-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
92 Kaler SG. Microbial peptide de-coppers mitochondria: implications for Wilson disease. J Clin Invest 2016;126:2412-4. [PMID: 27322063 DOI: 10.1172/JCI88617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
93 Wallace DF, Dooley JS. ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet 2020;139:1065-75. [PMID: 32248359 DOI: 10.1007/s00439-020-02161-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
94 Espinós C, Ferenci P. Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice? JHEP Rep 2020;2:100114. [PMID: 32613181 DOI: 10.1016/j.jhepr.2020.100114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Ochoa Palominos A, Ibáñez Samaniego L, Catalina Rodríguez MV, Pajares Díaz J, Clemente Ricote G. [Wilson's disease: clinical spectrum of liver disease]. Gastroenterol Hepatol 2013;36:86-91. [PMID: 23089210 DOI: 10.1016/j.gastrohep.2012.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Yu H, Xie JJ, Chen YC, Dong QY, Dong Y, Ni W, Wu ZY. Clinical features and outcome in patients with osseomuscular type of Wilson's disease. BMC Neurol 2017;17:34. [PMID: 28212618 DOI: 10.1186/s12883-017-0818-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
97 Wijayasiri P, Hayre J, Nicholson ES, Kaye P, Wilkes EA, Evans J, Aithal GP, Jones G, Pearce F, Aravinthan AD. Estimating the clinical prevalence of Wilson's disease in the UK. JHEP Rep 2021;3:100329. [PMID: 34381985 DOI: 10.1016/j.jhepr.2021.100329] [Reference Citation Analysis]
98 Kumar V, Singh AP, Wheeler N, Galindo CL, Kim JJ. Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system. Expert Opin Drug Saf 2021;:1-8. [PMID: 34259127 DOI: 10.1080/14740338.2021.1956460] [Reference Citation Analysis]
99 Broniek-Kowalik K, Dzieżyc K, Litwin T, Członkowska A, Szaflik JP. Anterior segment optical coherence tomography (AS-OCT) as a new method of detecting copper deposits forming the Kayser-Fleischer ring in patients with Wilson disease. Acta Ophthalmol 2019;97:e757-60. [PMID: 30635971 DOI: 10.1111/aos.14009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
100 Leung M, Wu Lanzafame J, Medici V. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations. J Investig Med High Impact Case Rep 2020;8:2324709619896876. [PMID: 31920114 DOI: 10.1177/2324709619896876] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
101 Cassis L, Cortès-Saladelafont E, Molero-Luis M, Yubero D, González MJ, Ormazábal A, Fons C, Jou C, Sierra C, Castejon Ponce E, Ramos F, Armstrong J, O'Callaghan MM, Casado M, Montero R, Meavilla-Olivas S, Artuch R, Barić I, Bartoloni F, Bellettato CM, Bonifazi F, Ceci A, Cvitanović-Šojat L, Dali CI, D'Avanzo F, Fumic K, Giannuzzi V, Lampe C, Scarpa M, Garcia-Cazorla Á. Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders. Orphanet J Rare Dis 2015;10:164. [PMID: 26714856 DOI: 10.1186/s13023-015-0376-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
102 Liu Y, Teng L, Yin B, Meng H, Yin X, Huan S, Song G, Zhang XB. Chemical Design of Activatable Photoacoustic Probes for Precise Biomedical Applications. Chem Rev 2022. [PMID: 35234464 DOI: 10.1021/acs.chemrev.1c00875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
103 Schilsky ML. A century for progress in the diagnosis of Wilson disease. Journal of Trace Elements in Medicine and Biology 2014;28:492-4. [DOI: 10.1016/j.jtemb.2014.06.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
104 Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med 2019;7:S65. [PMID: 31179302 DOI: 10.21037/atm.2018.12.53] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
105 Squitti R, Ghidoni R, Simonelli I, Ivanova ID, Colabufo NA, Zuin M, Benussi L, Binetti G, Cassetta E, Rongioletti M, Siotto M. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators. Journal of Trace Elements in Medicine and Biology 2018;45:181-8. [DOI: 10.1016/j.jtemb.2017.11.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
106 Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. [PMID: 23451000 DOI: 10.3238/arztebl.2013.0085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
107 García-poyo MC, Bérail S, Ronzani AL, Rello L, García-gonzález E, Lelièvre B, Cales P, Nakadi FV, Aramendía M, Resano M, Pécheyran C. Laser ablation of microdroplets for copper isotopic analysis via MC-ICP-MS. Analysis of serum microsamples for the diagnosis and follow-up treatment of Wilson's disease. J Anal At Spectrom 2021;36:968-80. [DOI: 10.1039/d0ja00494d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
108 Azova S, Rice T, Garcia-Delgar B, Coffey BJ. New-Onset Psychosis in an Adolescent with Wilson's Disease. J Child Adolesc Psychopharmacol 2016;26:301-4. [PMID: 27097017 DOI: 10.1089/cap.2016.29106.bjc] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
109 Kido J, Matsumoto S, Sakamoto R, Mitsubuchi H, Inomata Y, Nakamura K. Recovery of severe acute liver failure without transplantation in patients with Wilson disease. Pediatr Transplant. 2018;22:e13292. [PMID: 30368998 DOI: 10.1111/petr.13292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
110 Kohlmeier M. How Nutrients are Affected by Genetics. Nutrigenetics. Elsevier; 2013. pp. 103-221. [DOI: 10.1016/b978-0-12-385900-6.00004-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Chanpong A, Dhawan A. Long-Term Urinary Copper Excretion on Chelation Therapy in Children with Wilson Disease. J Pediatr Gastroenterol Nutr 2021;72:210-5. [PMID: 33369596 DOI: 10.1097/MPG.0000000000002982] [Reference Citation Analysis]
112 Xu L, Liu B, Liu Z, Tang N, She C, Wang J, Zang B, Yang Y. Co-occurrence of Wilson's disease and systemic lupus erythematosus: a case report and literature review. BMC Gastroenterol 2021;21:229. [PMID: 34020599 DOI: 10.1186/s12876-021-01814-5] [Reference Citation Analysis]
113 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 55.7] [Reference Citation Analysis]
114 Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, Weiss KH, Gauss A. Long‐term evaluation of urinary copper excretion and non‐caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis 2019;42:371-80. [DOI: 10.1002/jimd.12046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
115 Alam S, Lal BB, Sood V, Rawat D. Pediatric Acute-on-Chronic Liver Failure in a Specialized Liver Unit: Prevalence, Profile, Outcome, and Predictive Factors. J Pediatr Gastroenterol Nutr. 2016;63:400-405. [PMID: 26967824 DOI: 10.1097/mpg.0000000000001179] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
116 Dong Y, Wang RM, Yang GM, Yu H, Xu WQ, Xie JJ, Zhang Y, Chen YC, Ni W, Wu ZY. Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson's Disease. Clin Gastroenterol Hepatol 2021;19:590-6. [PMID: 32485301 DOI: 10.1016/j.cgh.2020.05.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594 [PMID: 27920479 DOI: 10.3748/wjg.v22.i43.9586] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
118 Altraif I, Handoo FA, Al Ghamdi H, Aljumah A, Al Jumah M, Afzal M. Presentation, diagnosis and outcome of predominantly hepatic Wilson's disease in adult Saudi patients: a single centre experience. Saudi J Gastroenterol 2012;18:334-8. [PMID: 23006462 DOI: 10.4103/1319-3767.101135] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
119 Guillaud O, Brunet AS, Mallet I, Dumortier J, Pelosse M, Heissat S, Rivet C, Lachaux A, Bost M. Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease. Liver Int 2018;38:350-7. [PMID: 28719006 DOI: 10.1111/liv.13520] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
120 Poujois A, Woimant F. Wilson's disease: A 2017 update. Clinics and Research in Hepatology and Gastroenterology 2018;42:512-20. [DOI: 10.1016/j.clinre.2018.03.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
121 Malbul K, Katwal S, Khetan S, Aryal N. A case report on serendipitous diagnosis of wilson's disease in a child with brucellosis and pseudomonal infection. Clin Case Rep 2021;9:e04178. [PMID: 34194770 DOI: 10.1002/ccr3.4178] [Reference Citation Analysis]
122 Pal A, Kumar A, Prasad R. Predictive association of copper metabolism proteins with Alzheimer’s disease and Parkinson’s disease: a preliminary perspective. Biometals 2014;27:25-31. [DOI: 10.1007/s10534-013-9702-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
123 Zhou J, Zhang Q, Zhao Y, Chen M, Zhou S, Cheng Y. Early Diagnosis of Wilson’s Disease in Children in Southern China by Using Common Parameters. Front Genet 2022;13:788658. [DOI: 10.3389/fgene.2022.788658] [Reference Citation Analysis]
124 Shah D. Wilson’s disease: Hepatic manifestations. Disease-a-Month 2014;60:465-74. [DOI: 10.1016/j.disamonth.2014.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
125 Weiss KH, Askari FK, Czlonkowska A, Ferenci P, Bronstein JM, Bega D, Ala A, Nicholl D, Flint S, Olsson L, Plitz T, Bjartmar C, Schilsky ML. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study. Lancet Gastroenterol Hepatol. 2017;2:869-876. [PMID: 28988934 DOI: 10.1016/s2468-1253(17)30293-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 10.4] [Reference Citation Analysis]
126 Shimamura Y, Maeda T, Gocho Y, Ogawa Y, Tsuji K, Takizawa H. Immunoglobulin A nephropathy secondary to Wilson's disease: a case report and literature review. CEN Case Rep 2019;8:61-6. [PMID: 30255238 DOI: 10.1007/s13730-018-0365-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
127 Gao J, Brackley S, Mann JP. The global prevalence of Wilson disease from next-generation sequencing data. Genet Med 2019;21:1155-63. [PMID: 30254379 DOI: 10.1038/s41436-018-0309-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
128 Panzer M, Viveiros A, Schaefer B, Baumgartner N, Seppi K, Djamshidian A, Todorov T, Griffiths WJH, Schott E, Schuelke M, Eurich D, Stättermayer AF, Bomford A, Foskett P, Vodopiutz J, Stauber R, Pertler E, Morell B, Tilg H, Müller T, Kiechl S, Jimenez-Heredia R, Weiss KH, Hahn SH, Janecke A, Ferenci P, Zoller H. Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease. Hepatol Commun 2022. [PMID: 35271763 DOI: 10.1002/hep4.1922] [Reference Citation Analysis]
129 Kalita J, Kumar V, Misra UK, Bora HK. Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum. Neurotox Res 2020;37:904-12. [PMID: 31811585 DOI: 10.1007/s12640-019-00140-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
130 Weiss KH, Kruse C, Manolaki N, Zuin M, Ferenci P, van Scheppingen D, Wijnberg L, de Koning CE, Dhawan A. Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine. Eur J Gastroenterol Hepatol 2022. [PMID: 35482910 DOI: 10.1097/MEG.0000000000002387] [Reference Citation Analysis]
131 Yuan ZF, Wu W, Yu YL, Shen J, Mao SS, Gao F, Xia ZZ. Novel mutations of the ATP7B gene in Han Chinese families with pre-symptomatic Wilson's disease. World J Pediatr 2015;11:255-60. [PMID: 26253413 DOI: 10.1007/s12519-015-0031-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
132 Santiago R, Gottrand F, Debray D, Bridoux L, Lachaux A, Morali A, Lapeyre D, Lamireau T. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers. Journal of Pediatric Gastroenterology & Nutrition 2015;61:613-8. [DOI: 10.1097/mpg.0000000000000926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
133 Penon-Portmann M, Lotz-Esquivel S, Chavez Carrera A, Jiménez-Hernández M, Alvarado-Romero D, Segura-Cordero S, Rimolo-Donadio F, Hevia-Urrutia F, Mora-Guevara A, Saborío-Rocafort M, Jiménez-Arguedas G, Badilla-Porras R. Wilson disease in Costa Rica: Pediatric phenotype and genotype characterization. JIMD Rep 2020;52:55-62. [PMID: 32154060 DOI: 10.1002/jmd2.12098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Udompap P, Kim D, Kim WR. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol. 2015;13:2031-2041. [PMID: 26291665 DOI: 10.1016/j.cgh.2015.08.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
135 Van Biervliet S, Küry S, De Bruyne R, Vanakker OM, Schmitt S, Vande Velde S, Blouin E, Bézieau S. Clinical zinc deficiency as early presentation of Wilson disease. J Pediatr Gastroenterol Nutr 2015;60:457-9. [PMID: 25825851 DOI: 10.1097/MPG.0000000000000628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
136 Zhi Y, Sun Y, Jiao Y, Pan C, Wu Z, Liu C, Su J, Zhou J, Shang D, Niu J, Hua R, Yin P. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease. Front Pharmacol 2021;12:754185. [PMID: 34880754 DOI: 10.3389/fphar.2021.754185] [Reference Citation Analysis]
137 Seessle J, Gotthardt DN, Schäfer M, Gohdes A, Pfeiffenberger J, Ferenci P, Stremmel W, Weiss KH. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy. J Inherit Metab Dis 2016;39:125-30. [DOI: 10.1007/s10545-015-9866-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
138 Carrier P, Debette-Gratien M, Girard M, Jacques J, Nubukpo P, Loustaud-Ratti V. Liver Illness and Psychiatric Patients. Hepat Mon 2016;16:e41564. [PMID: 28123443 DOI: 10.5812/hepatmon.41564] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
139 Huang Y, Takatsuki M, Soyama A, Hidaka M, Ono S, Adachi T, Hara T, Okada S, Hamada T, Eguchi S. Living Donor Liver Transplantation for Wilson's Disease Associated with Fulminant Hepatic Failure: A Case Report. Am J Case Rep 2018;19:304-8. [PMID: 29549236 DOI: 10.12659/ajcr.907494] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
140 Kerkhof M, Honkoop P. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score. Hepatology 2014;59:1645-7. [PMID: 24002824 DOI: 10.1002/hep.26719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
141 Singanayagam A, Bernal W. Update on acute liver failure: . Current Opinion in Critical Care 2015;21:134-41. [DOI: 10.1097/mcc.0000000000000187] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
142 Barada K, El Haddad A, Katerji M, Jomaa M, Usta J. Wilson’s disease in Lebanon and regional countries: Homozygosity and hepatic phenotype predominance. World J Gastroenterol 2017; 23(36): 6715-6725 [PMID: 29085216 DOI: 10.3748/wjg.v23.i36.6715] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
143 Alam S, Sood V. Metabolic Liver Disease: When to Suspect and How to Diagnose? Indian J Pediatr. 2016;83:1321-1333. [PMID: 27130505 DOI: 10.1007/s12098-016-2097-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
144 Guttmann S, Bernick F, Naorniakowska M, Michgehl U, Groba SR, Socha P, Zibert A, Schmidt HH. Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease. Front Pediatr 2018;6:106. [PMID: 29761093 DOI: 10.3389/fped.2018.00106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Pal A, kumar Vasishta R, Prasad R. Hepatic and Hippocampus Iron Status is not Altered in Response to Increased Serum Ceruloplasmin and Serum “Free” Copper in Wistar Rat Model for Non-Wilsonian Brain Copper Toxicosis. Biol Trace Elem Res 2013;154:403-11. [DOI: 10.1007/s12011-013-9753-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
146 Liebe R, Esposito I, Bock HH, Vom Dahl S, Stindt J, Baumann U, Luedde T, Keitel V. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol 2021;74:1455-71. [PMID: 33577920 DOI: 10.1016/j.jhep.2021.01.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
147 Hwang J, Yoon HM, Jung AY, Lee JS, Kim KM, Oh SH, Cho YA. Diagnostic Performance of Ultrasound Elastography and Serologic Fibrosis Indices for Evaluation of Hepatic Involvement in Wilson Disease. J Ultrasound Med 2020;39:2231-42. [PMID: 32401363 DOI: 10.1002/jum.15334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Andrade RJ, Robles‐díaz M. Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice. Liver Int 2019;40:6-17. [DOI: 10.1111/liv.14271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
149 Kim P, Zhang CC, Thoröe-Boveleth S, Weiskirchen S, Gaisa NT, Buhl EM, Stremmel W, Merle U, Weiskirchen R. Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry. Biomedicines 2020;8:E356. [PMID: 32948070 DOI: 10.3390/biomedicines8090356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Dzieżyc K, Litwin T, Chabik G, Gramza K, Członkowska A. Families with Wilson's disease in subsequent generations: Clinical and genetic analysis: Wilson's Disease in Subsequent Generations. Mov Disord 2014;29:1828-32. [DOI: 10.1002/mds.26057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
151 Rustgi VK, Gupta K, Tait C, Bhurwal A, Kabaria S, Catalano C, Li Y, Minacapelli CD. Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States. Hepatol Commun 2021. [PMID: 34559472 DOI: 10.1002/hep4.1812] [Reference Citation Analysis]
152 Członkowska A, Litwin T. Treatment of Wilson’s disease – another point of view. Expert Opinion on Orphan Drugs 2015;3:239-43. [DOI: 10.1517/21678707.2015.1016907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
153 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 155] [Article Influence: 66.0] [Reference Citation Analysis]
154 Zou L, Song Y, Zhou X, Chu J, Tang X. Regional morphometric abnormalities and clinical relevance in Wilson's disease: REGIONAL MORPHOMETRIC ABNORMALITIES IN WD. Mov Disord 2019;34:545-54. [DOI: 10.1002/mds.27641] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
155 Członkowska A, Litwin T, Dzieżyc K, Karliński M, Bring J, Bjartmar C. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale. BMC Neurol 2018;18:34. [PMID: 29621974 DOI: 10.1186/s12883-018-1039-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
156 Mitroiu M, Oude Rengerink K, Pontes C, Sancho A, Vives R, Pesiou S, Fontanet JM, Torres F, Nikolakopoulos S, Pateras K, Rosenkranz G, Posch M, Urach S, Ristl R, Koch A, Loukia S, van der Lee JH, Roes KCB. Applicability and added value of novel methods to improve drug development in rare diseases. Orphanet J Rare Dis 2018;13:200. [PMID: 30419965 DOI: 10.1186/s13023-018-0925-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
157 ShenTu Y, Mi X, Tang D, Jiang Y, Gao L, Ma X, Zhou B, Yang W, Shi J, Lan D, Chen G, Gong L. Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes. Clin Chim Acta 2021;521:258-63. [PMID: 34332988 DOI: 10.1016/j.cca.2021.07.026] [Reference Citation Analysis]
158 Kumar A, Sharma P, Prasad R, Pal A. An urgent need to assess safe levels of inorganic copper in nutritional supplements/parenteral nutrition for subset of Alzheimer’s disease patients. NeuroToxicology 2019;73:168-74. [DOI: 10.1016/j.neuro.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
159 Weiskirchen S, Kim P, Weiskirchen R. Laser Ablation Inductively Coupled Plasma Spectrometry: Metal Imaging in Experimental and Clinical Wilson Disease. Inorganics 2019;7:54. [DOI: 10.3390/inorganics7040054] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
160 Schilsky ML. Wilson disease: Clinical manifestations, diagnosis, and treatment. Clin Liver Dis (Hoboken) 2014;3:104-7. [PMID: 30992899 DOI: 10.1002/cld.349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
161 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
162 Harada M. Management for acute liver failure of Wilson disease: Indication for liver transplantation. Hepatol Res 2017;47:281-2. [PMID: 27061913 DOI: 10.1111/hepr.12717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
163 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
164 Armer J, De Goede C. How to use tests for disorders of copper metabolism. Arch Dis Child Educ Pract Ed 2017;102:319-27. [DOI: 10.1136/archdischild-2016-310960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
165 Antczak-Kowalska M, Członkowska A, Litwin T, Nehring P, Niewada M, Przybyłkowski A. Gastropathy in patients with Wilson disease. Scand J Gastroenterol 2020;55:14-7. [PMID: 31865812 DOI: 10.1080/00365521.2019.1703035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Alam S, Lal BB. Metabolic Liver Diseases Presenting as Acute Liver Failure in Children. Indian Pediatr 2016;53:695-701. [PMID: 27395834 DOI: 10.1007/s13312-016-0913-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
167 Kelly C, Pericleous M. Wilson disease: more than meets the eye. Postgrad Med J 2018;94:335-47. [PMID: 29449431 DOI: 10.1136/postgradmedj-2017-135381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
168 AlDubayan SH, Conway JR, Camp SY, Witkowski L, Kofman E, Reardon B, Han S, Moore N, Elmarakeby H, Salari K, Choudhry H, Al-Rubaish AM, Al-Sulaiman AA, Al-Ali AK, Taylor-Weiner A, Van Allen EM. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma. JAMA 2020;324:1957-69. [PMID: 33201204 DOI: 10.1001/jama.2020.20457] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
169 Giorgi C, Marchi S, Simoes ICM, Ren Z, Morciano G, Perrone M, Patalas-Krawczyk P, Borchard S, Jędrak P, Pierzynowska K, Szymański J, Wang DQ, Portincasa P, Węgrzyn G, Zischka H, Dobrzyn P, Bonora M, Duszynski J, Rimessi A, Karkucinska-Wieckowska A, Dobrzyn A, Szabadkai G, Zavan B, Oliveira PJ, Sardao VA, Pinton P, Wieckowski MR. Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases. Int Rev Cell Mol Biol 2018;340:209-344. [PMID: 30072092 DOI: 10.1016/bs.ircmb.2018.05.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 16.3] [Reference Citation Analysis]
170 BioMed Central. Correction to: Hepatology, Medicine and Policy: Articles with DOIs 10.1186/s41124-016-0014-8, 10.1186/s41124-016-0013-9 and 10.1186/s41124-016-0012-x. Hepatol Med Policy 2018;3:13. [PMID: 30480669 DOI: 10.1186/s41124-018-0042-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
171 Vierling JM, Sussman NL. Wilson Disease in Adults. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 165-77. [DOI: 10.1016/b978-0-12-810532-0.00016-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
172 Chevalier K, Mauget-faÿsse M, Vasseur V, Azar G, Obadia MA, Poujois A. Eye Involvement in Wilson’s Disease: A Review of the Literature. JCM 2022;11:2528. [DOI: 10.3390/jcm11092528] [Reference Citation Analysis]
173 Lai S, Huang YQ, Liu AQ, Wu HW. Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases. J Clin Pharm Ther 2017;42:783-5. [PMID: 28635014 DOI: 10.1111/jcpt.12576] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
174 Lorincz MT. Wilson disease and related copper disorders. Neurogenetics, Part I. Elsevier; 2018. pp. 279-92. [DOI: 10.1016/b978-0-444-63233-3.00018-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
175 Schilsky ML. Long-term outcome for Wilson disease: 85% good. Clin Gastroenterol Hepatol 2014;12:690-1. [PMID: 24246766 DOI: 10.1016/j.cgh.2013.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
176 Germani G, Battistella S, Ulinici D, Zanetto A, Shalaby S, Pellone M, Gambato M, Senzolo M, Russo FP, Burra P. Drug induced liver injury: from pathogenesis to liver transplantation. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.20.02795-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Socha P, Czlonkowska A, Janczyk W, Litwin T. Wilson's disease- management and long term outcomes. Best Pract Res Clin Gastroenterol 2022;56-57:101768. [PMID: 35331405 DOI: 10.1016/j.bpg.2021.101768] [Reference Citation Analysis]
178 Durairaj J, Shanbhag ER, Veena P, Gowda M, Keepanasseril A. Wilson's disease presenting during pregnancy: A diagnostic and therapeutic dilemma. Obstet Med 2018;11:148-50. [PMID: 30214483 DOI: 10.1177/1753495X17743162] [Reference Citation Analysis]
179 Mi X, Li Z, Yan J, Li Y, Zheng J, Zhuang Z, Yang W, Gong L, Shi J. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models. Biochim Biophys Acta Mol Basis Dis 2020;1866:165842. [PMID: 32446740 DOI: 10.1016/j.bbadis.2020.165842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Patil M, Sheth KA, Krishnamurthy AC, Devarbhavi H. A review and current perspective on Wilson disease. J Clin Exp Hepatol. 2013;3:321-336. [PMID: 25755520 DOI: 10.1016/j.jceh.2013.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
181 Bostantjopoulou S, Stathis P, Konitsiotis S. Wilson’s Disease: Neurological Aspects, Clinical Manifestations, and Treatment Considerations. In: Falup-pecurariu C, Ferreira J, Martinez-martin P, Chaudhuri KR, editors. Movement Disorders Curricula. Vienna: Springer; 2017. pp. 343-54. [DOI: 10.1007/978-3-7091-1628-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
182 Güngör Ş, Selimoğlu MA, Varol Fİ, Güngör S, Üremiş MM. The effects of iron and zinc status on prognosis in pediatric Wilson’s disease. Journal of Trace Elements in Medicine and Biology 2019;55:33-8. [DOI: 10.1016/j.jtemb.2019.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
183 Bembenek JP, Kurczych K, Członkowska A. TMS-induced motor evoked potentials in Wilson's disease: a systematic literature review. Bioelectromagnetics 2015;36:255-66. [PMID: 25808411 DOI: 10.1002/bem.21909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Kalita J, Misra UK, Kumar V, Parashar V. Predictors of seizure in Wilson disease: A clinico-radiological and biomarkers study. Neurotoxicology 2019;71:87-92. [PMID: 30583001 DOI: 10.1016/j.neuro.2018.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
185 Xu MB, Rong PQ, Jin TY, Zhang PP, Liang HY, Zheng GQ. Chinese Herbal Medicine for Wilson's Disease: A Systematic Review and Meta-Analysis. Front Pharmacol 2019;10:277. [PMID: 31001112 DOI: 10.3389/fphar.2019.00277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
186 Schroeder SM, Matsukuma KE, Medici V. Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features. Ann Transl Med 2021;9:1394. [PMID: 34733946 DOI: 10.21037/atm-21-2264] [Reference Citation Analysis]
187 Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J Hepatol 2015; 7(29): 2859-2870 [PMID: 26692151 DOI: 10.4254/wjh.v7.i29.2859] [Cited by in Crossref: 78] [Cited by in F6Publishing: 49] [Article Influence: 11.1] [Reference Citation Analysis]
188 Hou H, Chen D, Liu J, Feng L, Zhang J, Liang X, Xu Y, Li X. Zinc monotherapy for young patients with oligosymptomatic Wilson disease: A single center, retrospective study. Clin Res Hepatol Gastroenterol 2021;45:101623. [PMID: 33662781 DOI: 10.1016/j.clinre.2021.101623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Wei T, Hao W, Tang L, Wu H, Huang S, Yang Y, Qian N, Liu J, Yang W, Duan X. Comprehensive RNA-Seq Analysis of Potential Therapeutic Targets of Gan-Dou-Fu-Mu Decoction for Treatment of Wilson Disease Using a Toxic Milk Mouse Model. Front Pharmacol 2021;12:622268. [PMID: 33935715 DOI: 10.3389/fphar.2021.622268] [Reference Citation Analysis]
190 Rojas H. Wilson Disease: What Does Copper Have to Do With It? The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.01.024] [Reference Citation Analysis]
191 Dzieżyc K, Karliński M, Litwin T, Członkowska A. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients. Eur J Neurol 2014;21:332-7. [PMID: 24313946 DOI: 10.1111/ene.12320] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
192 Schaefer M, Gotthardt DN, Didion C, Stremmel W, Weiss KH. Increased Prevalence of Subcutaneous Lipomas in Patients With Wilson Disease. Journal of Clinical Gastroenterology 2015;49:e61-3. [DOI: 10.1097/mcg.0000000000000248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
193 Rabiee A, Hamilton JPA. Pregnancy in Wilson disease. Hepatology 2018;67:1201-3. [PMID: 29077220 DOI: 10.1002/hep.29619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Poon KS, Tan KM, Koay ES. Targeted next-generation sequencing of the ATP7B gene for molecular diagnosis of Wilson disease. Clin Biochem 2016;49:166-71. [PMID: 26483271 DOI: 10.1016/j.clinbiochem.2015.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
195 Shribman S, Warner TT, Dooley JS. Clinical presentations of Wilson disease. Ann Transl Med. 2019;7:S60. [PMID: 31179297 DOI: 10.21037/atm.2019.04.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
196 Choudhary NS, Saigal S, Saraf N, Rastogi A, Goja S, Bhangui P, Thiagrajan S, Gautam D, Govil D, Vohra V, Soin AS. Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single Center Experience. J Clin Exp Hepatol 2018;8:132-5. [PMID: 29892175 DOI: 10.1016/j.jceh.2017.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
197 Camarata MA, Ala A, Coskun AK, Deng Y, Gonzalez-Peralta RP, Maciejewski KR, Patel A, Rubman S, To U, Tomlin R, Schilsky ML, Zimbrean PC. The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease. J Acad Consult Liaison Psychiatry 2021;62:528-37. [PMID: 34044196 DOI: 10.1016/j.jaclp.2021.04.004] [Reference Citation Analysis]
198 Fineberg SK, West A, Na PJ, Oldham M, Schilsky M, Hawkins KA, Lee HB. Utility of pretransplant psychological measures to predict posttransplant outcomes in liver transplant patients: a systematic review. General Hospital Psychiatry 2016;40:4-11. [DOI: 10.1016/j.genhosppsych.2016.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
199 Tampaki M, Gatselis NK, Savvanis S, Koullias E, Saitis A, Gabeta S, Deutsch M, Manesis E, Dalekos GN, Koskinas J. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers. Eur J Gastroenterol Hepatol 2020;32:1545-52. [PMID: 32118851 DOI: 10.1097/MEG.0000000000001670] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Henriet T, Gana I, Ghaddar C, Barrio M, Cartigny Y, Yagoubi N, Do B, Tamarit JL, Rietveld IB. Solid state stability and solubility of triethylenetetramine dihydrochloride. Int J Pharm 2016;511:312-21. [PMID: 27377012 DOI: 10.1016/j.ijpharm.2016.06.140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
201 Liggi M, Mais C, Demurtas M, Sorbello O, Demelia E, Civolani A, Demelia L. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease. Scandinavian Journal of Gastroenterology 2013;48:1452-8. [DOI: 10.3109/00365521.2013.845904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
202 Yang J, Huang Z, Yang H, Luo Y, You H, Chen D, Pei Z, Li X. Plasma neurofilament light chain as a biomarker in Wilson's disease. Parkinsonism Relat Disord 2021;95:5-10. [PMID: 34942565 DOI: 10.1016/j.parkreldis.2021.12.003] [Reference Citation Analysis]
203 Pöhler M, Guttmann S, Nadzemova O, Lenders M, Brand E, Zibert A, Schmidt HH, Sandfort V. CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B. PLoS One 2020;15:e0239411. [PMID: 32997714 DOI: 10.1371/journal.pone.0239411] [Reference Citation Analysis]
204 Sánchez-Monteagudo A, Ripollés E, Berenguer M, Espinós C. Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021;9:1100. [PMID: 34572285 DOI: 10.3390/biomedicines9091100] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
205 Carone M, Moreno S, Cangiotti M, Ottaviani MF, Wang P, Carloni R, Appelhans D. DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes. Langmuir 2020;36:12816-29. [PMID: 32993292 DOI: 10.1021/acs.langmuir.0c01776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Liu M, Jin M, Chen X, Wan B, Guo Y, Sheng M, Chen L, Zhao L, Huang D, Li Y. ATP7B Mutation Detection and Pathogenicity Analysis: One Atypical Case of Wilson's Disease with Adrenocortical Insufficiency. J Mol Neurosci 2018;64:20-8. [PMID: 29181760 DOI: 10.1007/s12031-017-0997-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
207 Zhou ZH, Wu YF, Yan Y, Liu AQ, Yu QY, Peng ZX, Wang GQ, Hong MF. Persistence with medical treatment for Wilson disease in China based on a single center's survey research. Brain Behav 2021;11:e02168. [PMID: 33949793 DOI: 10.1002/brb3.2168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Li G, Wu R, Tong R, Bo B, Zhao Y, Gillen KM, Spincemaille P, Ku Y, Du Y, Wang Y, Wang X, Li J. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease. Mov Disord 2020;35:1787-95. [PMID: 32681698 DOI: 10.1002/mds.28141] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
209 Zaim O, Diouf A, El Bari N, Lagdali N, Benelbarhdadi I, Ajana FZ, Llobet E, Bouchikhi B. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue. Anal Chim Acta 2021;1184:339028. [PMID: 34625262 DOI: 10.1016/j.aca.2021.339028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Ferenci P. Diagnosis of Wilson disease. Handb Clin Neurol. 2017;142:171-180. [PMID: 28433100 DOI: 10.1016/b978-0-444-63625-6.00014-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
211 Siotto M, Simonelli I, Pasqualetti P, Mariani S, Caprara D, Bucossi S, Ventriglia M, Molinario R, Antenucci M, Rongioletti M, Rossini PM, Squitti R. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease. J Alzheimers Dis 2016;50:1181-9. [PMID: 26836154 DOI: 10.3233/JAD-150611] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
212 Mclaughlin J, Young T. Neurology in the psychiatric patient: how to think about differentials in altered mental status and diagnoses not to miss. BJPsych advances. [DOI: 10.1192/bja.2021.67] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-422. [PMID: 31421978 DOI: 10.1053/j.semdp.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
214 Brewer GJ. Treatment of Wilson’s disease: our patients deserve better. Expert Opinion on Orphan Drugs 2014;2:1245-8. [DOI: 10.1517/21678707.2014.975207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
215 Weiss KH, Członkowska A, Hedera P, Ferenci P. WTX101 – an investigational drug for the treatment of Wilson disease. Expert Opinion on Investigational Drugs 2018;27:561-7. [DOI: 10.1080/13543784.2018.1482274] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
216 Ibrahim W. Coexistence of seizure with Wilson's disease: a systematic review. Prog Neurol Psychiatry 2020;24:24-30. [DOI: 10.1002/pnp.559] [Reference Citation Analysis]
217 Li D, Wang J, Gao J. Primary breast cancer in a patient with Wilson disease: A case report. Medicine (Baltimore) 2019;98:e15266. [PMID: 31083157 DOI: 10.1097/MD.0000000000015266] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
218 Osterode W, Falkenberg G, Ferenci P, Wrba F. Quantitative trace element mapping in liver tissue from patients with Wilson`s disease determined by micro X-ray fluorescence. J Trace Elem Med Biol 2019;51:42-9. [PMID: 30466937 DOI: 10.1016/j.jtemb.2018.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
219 Kim H, Im I, Jeon JS, Kang E, Lee H, Jo S, Kim J, Woo D, Choi YJ, Kim HJ, Han J, Lee B, Kim J, Kim SK, Park H. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials 2022;286:121575. [DOI: 10.1016/j.biomaterials.2022.121575] [Reference Citation Analysis]
220 Schonfeld EA, Brown RS Jr. Genetic Causes of Liver Disease: When to Suspect a Genetic Etiology, Initial Lab Testing, and the Basics of Management. Med Clin North Am 2019;103:991-1003. [PMID: 31582009 DOI: 10.1016/j.mcna.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
221 Leung M, Aronowitz PB, Medici V. The Present and Future Challenges of Wilson's Disease Diagnosis and Treatment. Clin Liver Dis (Hoboken) 2021;17:267-70. [PMID: 33968387 DOI: 10.1002/cld.1041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
222 Bolia R, Srivastava A, Yachha SK, Poddar U. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease. Journal of Hepatology 2018;68:449-55. [DOI: 10.1016/j.jhep.2017.10.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
223 Güngör Ş, Selimoğlu MA, Varol Fİ, Güngör S. Pediatric Wilson's disease: findings in different presentations. A cross-sectional study. Sao Paulo Med J 2018;136:304-9. [PMID: 30304203 DOI: 10.1590/1516-3180.2018.0210230718] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
224 Stremmel W, Merle U, Weiskirchen R. Clinical features of Wilson disease. Ann Transl Med 2019;7:S61. [PMID: 31179298 DOI: 10.21037/atm.2019.01.20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
225 Motobayashi M, Fukuyama T, Nakayama Y, Sano K, Noda S, Hidaka Y, Amano Y, Ikeda S, Koike K, Inaba Y. Successful treatment of fulminant Wilson's disease without liver transplantation. Pediatr Int. 2014;56:429-432. [PMID: 24894932 DOI: 10.1111/ped.12291] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
226 Zarina A, Tolmane I, Kreile M, Chernushenko A, Cernevska G, Pukite I, Micule I, Krumina Z, Krumina A, Rozentale B, Piekuse L. Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease. Mol Genet Genomic Med 2017;5:405-9. [PMID: 28717664 DOI: 10.1002/mgg3.297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
227 Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Pediatric liver diseases: current challenges and future perspectives. Expert Rev Gastroenterol Hepatol 2016;10:255-65. [PMID: 26641319 DOI: 10.1586/17474124.2016.1129274] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
228 Smolinski L, Litwin T, Redzia-Ogrodnik B, Dziezyc K, Kurkowska-Jastrzebska I, Czlonkowska A. Brain volume is related to neurological impairment and to copper overload in Wilson's disease. Neurol Sci 2019;40:2089-95. [PMID: 31147855 DOI: 10.1007/s10072-019-03942-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
229 Schonfeld EA, Brown RS Jr. Genetic Testing in Liver Disease: What to Order, in Whom, and When. Clin Liver Dis 2017;21:673-86. [PMID: 28987255 DOI: 10.1016/j.cld.2017.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
230 Chen D, Zhou X, Hou H, Feng L, Liu J, Liang Y, Lin X, Zhang J, Wu C, Liang X, Pei Z, Li X. Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure. Ther Adv Neurol Disord 2016;9:310-6. [PMID: 27366238 DOI: 10.1177/1756285616641598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
231 Zischka H, Borchard S. Mitochondrial Copper Toxicity with a Focus on Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 65-75. [DOI: 10.1016/b978-0-12-810532-0.00008-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Mocchegiani F, Gemini S, Vincenzi P, Montalti R, Vecchi A, Nicolini D, Federici A, Coletta M, Pansini M, Lanari J, Svegliati Baroni G, Risaliti A, Vivarelli M. Liver transplantation in neurological Wilson's Disease: is there indication? A case report. Transplant Proc 2014;46:2360-4. [PMID: 25242788 DOI: 10.1016/j.transproceed.2014.07.059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
233 Gaur K, Vázquez-Salgado AM, Duran-Camacho G, Dominguez-Martinez I, Benjamín-Rivera JA, Fernández-Vega L, Sarabia LC, García AC, Pérez-Deliz F, Méndez Román JA, Vega-Cartagena M, Loza-Rosas SA, Acevedo XR, Tinoco AD. Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy. Inorganics (Basel) 2018;6:126. [PMID: 33912613 DOI: 10.3390/inorganics6040126] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
234 Dusek P, Litwin T, Członkowska A. Neurologic impairment in Wilson disease. Ann Transl Med 2019;7:S64. [PMID: 31179301 DOI: 10.21037/atm.2019.02.43] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
235 Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol 2021;75 Suppl 1:S36-48. [PMID: 34039491 DOI: 10.1016/j.jhep.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
236 Bekele N, Ewnetu F, Hailu T, Tegegne Z, Tadesse A. Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters. Case Rep Med 2020;2020:7650170. [PMID: 32774387 DOI: 10.1155/2020/7650170] [Reference Citation Analysis]
237 Członkowska A, Litwin T. Wilson disease - currently used anticopper therapy. Handb Clin Neurol 2017;142:181-91. [PMID: 28433101 DOI: 10.1016/B978-0-444-63625-6.00015-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
238 Squitti R, Pal A, Picozza M, Avan A, Ventriglia M, Rongioletti MC, Hoogenraad T. Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy. Biomolecules 2020;10:E1164. [PMID: 32784855 DOI: 10.3390/biom10081164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
239 Nussinson E, Shahbari A, Shibli F, Chervinsky E, Trougouboff P, Markel A. Diagnostic challenges of Wilson’s disease presenting as acute pancreatitis, cholangitis, and jaundice. World J Hepatol 2013; 5(11): 649-653 [PMID: 24303094 DOI: 10.4254/wjh.v5.i11.649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
240 Mayr T, Ferenci P, Weiler M, Fichtner A, Mehrabi A, Hoffmann GF, Mohr I, Pfeiffenberger J, Weiss KH, Teufel-Schäfer U. Optimized Trientine-dihydrochloride Therapy in Pediatric Patients With Wilson Disease: Is Weight-based Dosing Justified? J Pediatr Gastroenterol Nutr 2021;72:115-22. [PMID: 32804908 DOI: 10.1097/MPG.0000000000002902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Dzieżyc-Jaworska K, Litwin T, Członkowska A. Clinical manifestations of Wilson disease in organs other than the liver and brain. Ann Transl Med 2019;7:S62. [PMID: 31179299 DOI: 10.21037/atm.2019.03.30] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
242 Dohan A, Vargas O, Dautry R, Guerrache Y, Woimant F, Hamzi L, Boudiaf M, Poujois A, Faraoun SA, Soyer P. MR imaging features of focal liver lesions in Wilson disease. Abdom Radiol (NY) 2016;41:1811-24. [PMID: 27116011 DOI: 10.1007/s00261-016-0744-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Vilarinho S, Choi M, Jain D, Malhotra A, Kulkarni S, Pashankar D, Phatak U, Patel M, Bale A, Mane S, Lifton RP, Mistry PK. Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. J Hepatol 2014;61:1056-63. [PMID: 25016221 DOI: 10.1016/j.jhep.2014.06.038] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
244 Zheng Z, Xu M, Sun C, Wu Z, Dong Y. Acute-Onset Visual Impairment in Wilson's Disease: A Case Report and Literature Review. Front Neurol 2022;13:911882. [DOI: 10.3389/fneur.2022.911882] [Reference Citation Analysis]
245 Khalaf R, Phen C, Karjoo S, Wilsey M. Cholestasis beyond the Neonatal and Infancy Periods. Pediatr Gastroenterol Hepatol Nutr 2016;19:1-11. [PMID: 27066444 DOI: 10.5223/pghn.2016.19.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
246 Ferenci P, Ott P. Wilson's disease: Fatal when overlooked, curable when diagnosed. J Hepatol 2019;71:222-4. [PMID: 31126728 DOI: 10.1016/j.jhep.2019.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, Eder E, Ferenci P, Stremmel W, Weiskirchen R. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med 2015;19:806-14. [PMID: 25704483 DOI: 10.1111/jcmm.12497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
248 Sharma S, Lal SB, Sachdeva M, Bhatia A, Varma N. Role of Granulocyte Colony Stimulating Factor on the Short-Term Outcome of Children with Acute on Chronic Liver Failure. J Clin Exp Hepatol 2020;10:201-10. [PMID: 32405176 DOI: 10.1016/j.jceh.2019.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
249 Schaefer M, Gotthardt DN, Ganion N, Wohnsland S, Seessle J, Stremmel W, Pfeiffenberger J, Weiss KH. Wilson disease: Health-related quality of life and risk for depression. Clinics and Research in Hepatology and Gastroenterology 2016;40:349-56. [DOI: 10.1016/j.clinre.2015.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
250 Cai S, Gong JY, Yang J, Wang JS. Anemia following zinc treatment for Wilson's disease: a case report and literature review. BMC Gastroenterol 2019;19:120. [PMID: 31288754 DOI: 10.1186/s12876-019-1038-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Kara N, Seyyar SA, Saygili O, Seyyar M, Gulsen MT, Gungor K. Anterior Segment Parameters in Patients With Wilson Disease. Cornea 2018;37:466-9. [DOI: 10.1097/ico.0000000000001422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Erdol S, Karakaya S, Saglam H, Tarim O. Chromhidrosis due to exogenous oxidizing heavy metals: Clinical and laboratory findings. Pediatr Dermatol 2018;35:448-52. [DOI: 10.1111/pde.13491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Hao W, Wei T, Yang W, Yang Y, Cheng T, Li X, Dong W, Jiang H, Qian N, Wang H, Wang M. Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Upper Limb Dystonia in Patients With Wilson's Disease: A Randomized Controlled Trial. Front Neurol 2021;12:783365. [PMID: 34970214 DOI: 10.3389/fneur.2021.783365] [Reference Citation Analysis]
254 Ferenci P, Litwin T, Seniow J, Czlonkowska A. Encephalopathy in Wilson disease: copper toxicity or liver failure? J Clin Exp Hepatol 2015;5:S88-95. [PMID: 26041965 DOI: 10.1016/j.jceh.2014.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
255 Ranucci G, Di Dato F, Spagnuolo MI, Vajro P, Iorio R. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. Orphanet J Rare Dis 2014;9:41. [PMID: 24661374 DOI: 10.1186/1750-1172-9-41] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
256 Hermann W, Huster D. [Diagnostics of Wilson's disease]. Nervenarzt 2018;89:115-23. [PMID: 29159549 DOI: 10.1007/s00115-017-0452-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
257 Rukunuzzaman M. Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases. Pediatr Gastroenterol Hepatol Nutr 2015;18:121-7. [PMID: 26157698 DOI: 10.5223/pghn.2015.18.2.121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
258 Stättermayer AF, Traussnigg S, Dienes HP, Aigner E, Stauber R, Lackner K, Hofer H, Stift J, Wrba F, Stadlmayr A. Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations. J Hepatol. 2015;63:156-163. [PMID: 25678388 DOI: 10.1016/j.jhep.2015.01.034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
259 Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Liver AISF. AISF position paper on liver disease and pregnancy. Dig Liver Dis. 2016;48:120-137. [PMID: 26747754 DOI: 10.1016/j.dld.2015.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
260 Ye S, Dai T, Leng B, Tang L, Jin L, Cao L. Genotype and clinical course in 2 Chinese Han siblings with Wilson disease presenting with isolated disabling premature osteoarthritis: A case report. Medicine (Baltimore) 2017;96:e8641. [PMID: 29381936 DOI: 10.1097/MD.0000000000008641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Litwin T, Dusek P, Skowrońska M, Członkowska A. Treatment of Wilson’s disease – an update. Expert Opinion on Orphan Drugs 2019;7:287-94. [DOI: 10.1080/21678707.2019.1638248] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
262 Kalita J, Kumar V, Misra UK, Kumar S. Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury. J Mol Neurosci 2021;71:338-46. [DOI: 10.1007/s12031-020-01654-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
263 Ott P, Ala A, Askari FK, Czlonkowska A, Hilgers RD, Poujois A, Roberts EA, Sandahl TD, Weiss KH, Ferenci P, Schilsky ML. Designing Clinical Trials in Wilson's Disease. Hepatology 2021;74:3460-71. [PMID: 34320232 DOI: 10.1002/hep.32074] [Reference Citation Analysis]
264 Leśniak M, Roessler-Górecka M, Członkowska A, Seniów J. Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson's disease. Neurol Sci 2021. [PMID: 34125323 DOI: 10.1007/s10072-021-05366-0] [Reference Citation Analysis]
265 van Meer S, de Man RA, van den Berg AP, Houwen RH, Linn FH, van Oijen MG, Siersema PD, van Erpecum KJ. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up. J Gastroenterol Hepatol. 2015;30:535-539. [PMID: 25160780 DOI: 10.1111/jgh.12716] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
266 Poon KS, Teo ZH, Yap JH, Koay ES, Tan K. Challenges in molecular diagnosis of Wilson disease: viewpoint from the clinical laboratory. J Clin Pathol 2020;73:231-4. [PMID: 31796634 DOI: 10.1136/jclinpath-2019-206054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
267 Beinhardt S, Leiss W, Stättermayer AF, Graziadei I, Zoller H, Stauber R, Maieron A, Datz C, Steindl-Munda P, Hofer H. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol. 2014;12:683-689. [PMID: 24076416 DOI: 10.1016/j.cgh.2013.09.025] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
268 Sherman M. Surveillance for hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2014;28:783-93. [DOI: 10.1016/j.bpg.2014.08.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
269 Iorio GG, Conforti A, Vallone R, Carbone L, Matarazzo M, De Rosa A, De Rosa P, Picarelli S, Fedele F, Perruolo G, Formisano P, Iorio R, Alviggi C, Di Dato F. Reproductive function of long-term treated patients with hepatic onset of Wilson's disease: a prospective study. Reprod Biomed Online 2021;42:835-41. [PMID: 33549482 DOI: 10.1016/j.rbmo.2020.12.012] [Reference Citation Analysis]
270 Mulroy E, Stamelou M, Bhatia KP. How to approach a patient with parkinsonism - red flags for atypical parkinsonism. Int Rev Neurobiol 2019;149:1-34. [PMID: 31779810 DOI: 10.1016/bs.irn.2019.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Resano M, Aramendía M, Rello L, Calvo ML, Bérail S, Pécheyran C. Direct determination of Cu isotope ratios in dried urine spots by means of fs-LA-MC-ICPMS. Potential to diagnose Wilson's disease. J Anal At Spectrom 2013;28:98-106. [DOI: 10.1039/c2ja30262d] [Cited by in Crossref: 41] [Cited by in F6Publishing: 2] [Article Influence: 4.6] [Reference Citation Analysis]
272 Członkowska A, Litwin T, Karliński M, Dziezyc K, Chabik G, Czerska M. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease. Eur J Neurol 2014;21:599-606. [PMID: 24447648 DOI: 10.1111/ene.12348] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 8.4] [Reference Citation Analysis]
273 Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [DOI: 10.12998/wjcc.v10.i14.4334] [Reference Citation Analysis]
274 Moreno-Marro S, Barrachina-Bonet L, Páramo-Rodríguez L, Alonso-Ferreira V, Guardiola-Vilarroig S, Vicente E, García-López M, Palomar-Rodríguez J, Zoni AC, Zurriaga Ó, Cavero-Carbonell C; Grupo de trabajo Wilson-RAER. [Wilson's disease in Spain: validation of sources of information used by the Rare Diseases Registries]. Gac Sanit 2021;35:551-8. [PMID: 33010964 DOI: 10.1016/j.gaceta.2020.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
275 Tanner S. A History of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 1-11. [DOI: 10.1016/b978-0-12-810532-0.00001-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
276 Dubbioso R, Ranucci G, Esposito M, Di Dato F, Topa A, Quarantelli M, Matarazzo M, Santoro L, Manganelli F, Iorio R. Subclinical neurological involvement does not develop if Wilson's disease is treated early. Parkinsonism & Related Disorders 2016;24:15-9. [DOI: 10.1016/j.parkreldis.2016.01.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
277 Li Y, Ma J, Li B, Zhu X, Wang J. Cirrhosis of Wilson's disease: High and low cutoff using acoustic radiation force impulse (ARFI) -Comparison and combination with serum fibrosis index. Clin Hemorheol Microcirc 2021. [PMID: 34334385 DOI: 10.3233/CH-211219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Page S, Shaik L, Singh R, Rathore SS, Shah K. Neuropsychiatric Atypical Manifestation in Wilson's Disease: A Case Report and Literature Review. Cureus 2020;12:e9290. [PMID: 32832288 DOI: 10.7759/cureus.9290] [Reference Citation Analysis]
279 Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR; Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. [PMID: 33929376 DOI: 10.14309/ajg.0000000000001259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
280 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
281 Boga S, Jain D, Schilsky ML. Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment. Pediatr Gastroenterol Hepatol Nutr 2015;18:202-8. [PMID: 26473142 DOI: 10.5223/pghn.2015.18.3.202] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
282 Zhao SX, Zhang YG, Wang RQ, Li WC, Kong LB, Kong L, Nan YM. A Patient With Primary Biliary Cirrhosis Accompanied by Wilson’s Disease. Hepat Mon. 2016;16:e29077. [PMID: 27148382 DOI: 10.5812/hepatmon.29077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
283 Teodoro T, Neutel D, Lobo P, Geraldo AF, Conceição I, Rosa MM, Albuquerque L, Ferreira JJ. Recovery after copper-deficiency myeloneuropathy in Wilson’s disease. J Neurol 2013;260:1917-8. [DOI: 10.1007/s00415-013-6963-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
284 Ondrejkovičová M, Dražilová S, Drakulová M, Siles JL, Zemjarová Mezenská R, Jungová P, Fabián M, Rychlý B, Žigrai M. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease. BMC Gastroenterol 2020;20:95. [PMID: 32264837 DOI: 10.1186/s12876-020-01237-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
285 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson’s disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2017;44:71-5. [DOI: 10.1016/j.jtemb.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
286 Flatley S, Dube AK, Gleeson D. Histopathologist and clinician interface in diagnosis and management of autoimmune hepatitis. Frontline Gastroenterol 2022;13:e94-e101. [DOI: 10.1136/flgastro-2022-102192] [Reference Citation Analysis]
287 Ziemssen T, Akgun K, Członkowska A, Antos A, Bembenek J, Kurkowska-Jastrzębska I, Przybyłkowski A, Skowrońska M, Smolinski L, Litwin T. Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations. Mov Disord 2022. [PMID: 35114010 DOI: 10.1002/mds.28946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
288 Yamaguchi H, Nagase H, Tokumoto S, Tomioka K, Nishiyama M, Takeda H, Ninchoji T, Nagano C, Iijima K, Nozu K. Prevalence of Wilson disease based on genome databases in Japan. Pediatr Int 2021;63:918-22. [PMID: 33260258 DOI: 10.1111/ped.14565] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Squitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, Mariani S, Rongioletti M, Zanetti O, Congiu C, Rossini PM, Bonvicini C. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency. Mol Neurobiol 2017;54:671-81. [DOI: 10.1007/s12035-015-9664-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
290 Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res 2018;7:F1000 Faculty Rev-921. [PMID: 30002817 DOI: 10.12688/f1000research.14841.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
291 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
292 Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38:417-432. [PMID: 32279718 DOI: 10.1016/j.ncl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
293 Huang C, Fang M, Xiao X, Gao Z, Wang Y, Gao C. Genetic studies discover novel coding and non-coding mutations in patients with Wilson's disease in China. J Clin Lab Anal 2022;:e24459. [PMID: 35470480 DOI: 10.1002/jcla.24459] [Reference Citation Analysis]
294 Rodríguez-quiroga SA, Rosales J, Arakaki T, Cordoba M, González-morón D, Medina N, Garretto NS, Kauffman MA. Timely diagnosis of Wilson's disease using whole exome sequencing. Parkinsonism & Related Disorders 2015;21:1375-7. [DOI: 10.1016/j.parkreldis.2015.09.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
295 Di Dato F, Iorio R. Wilson disease: Many guidelines but still many unsolved doubts. Dig Liver Dis 2021;53:139-40. [PMID: 33214062 DOI: 10.1016/j.dld.2020.11.002] [Reference Citation Analysis]
296 Carta MG, Saba L, Moro MF, Demelia E, Sorbello O, Pintus M, Pintus E, Simavorian T, Akiskal H, Demelia L. Homogeneous magnetic resonance imaging of brain abnormalities in bipolar spectrum disorders comorbid with Wilson's disease. General Hospital Psychiatry 2015;37:134-8. [DOI: 10.1016/j.genhosppsych.2015.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
297 Ala A. Wilson's disease. Medicine 2019;47:814-7. [DOI: 10.1016/j.mpmed.2019.09.001] [Reference Citation Analysis]
298 Chen C, Shen B, Xiao JJ, Wu R, Duff Canning SJ, Wang XP. Currently Clinical Views on Genetics of Wilson's Disease. Chin Med J (Engl). 2015;128:1826-1830. [PMID: 26112727 DOI: 10.4103/0366-6999.159361] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
299 Pak K, Ordway S, Sadowski B, Canevari M, Torres D. Wilson's Disease and Iron Overload: Pathophysiology and Therapeutic Implications. Clin Liver Dis (Hoboken) 2021;17:61-6. [PMID: 33680437 DOI: 10.1002/cld.986] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 AlDhaleei W, AlAhmad M, Alhosani I. Wilson's Disease Presenting in Late Adult Life. Case Rep Gastroenterol 2021;15:142-6. [PMID: 33708062 DOI: 10.1159/000512422] [Reference Citation Analysis]
301 Tribl GG, Bor-seng-shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson?s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuro-Psiquiatr 2014;72:653-8. [DOI: 10.1590/0004-282x20140118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
302 Litwin T, Dzieżyc K, Karliński M, Chabik G, Czepiel W, Członkowska A. Early neurological worsening in patients with Wilson's disease. J Neurol Sci 2015;355:162-7. [PMID: 26071888 DOI: 10.1016/j.jns.2015.06.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 9.4] [Reference Citation Analysis]
303 Khadilkar S, Jaggi S, Patel B, Yadav R, Hanagandi P, Faria do Amaral LL. A practical approach to diseases affecting dentate nuclei. Clin Radiol 2016;71:107-19. [PMID: 26577296 DOI: 10.1016/j.crad.2015.09.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
304 Sturm E, Piersma FE, Tanner MS, Socha P, Roberts EA, Shneider BL. Controversies and Variation in Diagnosing and Treating Children With Wilson Disease: Results of an International Survey. Journal of Pediatric Gastroenterology & Nutrition 2016;63:82-7. [DOI: 10.1097/mpg.0000000000001102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
305 Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson’s disease. Journal of Clinical Neuroscience 2019;59:167-74. [DOI: 10.1016/j.jocn.2018.10.096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
306 Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, Alam S, Bavdekar A, Dhiman RK, Eapen CE, Goyal V, Mohan N, Kandadai RM, Sathiyasekaran M, Poddar U, Sibal A, Sankaranarayanan S, Srivastava A, Thapa BR, Wadia PM, Yachha SK, Dhawan A. Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9:74-98. [PMID: 30765941 DOI: 10.1016/j.jceh.2018.08.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
307 Joshi G, Dhingra D, Tekchandani U, Kaushik S. Kayser-Fleischer ring in Wilson's disease. QJM 2019;112:629. [PMID: 30690586 DOI: 10.1093/qjmed/hcz027] [Reference Citation Analysis]
308 Boga S, Jain D, Schilsky ML. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature. BMC Pharmacol Toxicol 2015;16:30. [PMID: 26589720 DOI: 10.1186/s40360-015-0031-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
309 Dathe K, Beck E, Schaefer C. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. Reproductive Toxicology 2016;65:39-45. [DOI: 10.1016/j.reprotox.2016.06.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
310 Albright CM, Fay EE. Chronic Liver Disease in the Obstetric Patient. Clin Obstet Gynecol 2020;63:193-210. [PMID: 31789831 DOI: 10.1097/GRF.0000000000000502] [Reference Citation Analysis]
311 Braga F, Szőke D, Valente C, Panteghini M. Biologic variation of copper, ceruloplasmin and copper/ceruloplasmin ratio (Cu:Cp) in serum. Clin Chim Acta 2013;415:295-6. [PMID: 23165218 DOI: 10.1016/j.cca.2012.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
312 Dal MB, Alim A, Acarli K. The advantage of early liver transplantation for Wilson's disease using living donors. Prz Gastroenterol 2021;16:213-8. [PMID: 34584582 DOI: 10.5114/pg.2021.108990] [Reference Citation Analysis]
313 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Element bioimaging of liver needle biopsy specimens from patients with Wilson’s disease by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2016;35:97-102. [DOI: 10.1016/j.jtemb.2016.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
314 Hadžić N, Deheragoda M, Dhawan A. Managing pre-symptomatic Wilson disease in genetic era – More questions than answers. Clinics and Research in Hepatology and Gastroenterology 2017;41:626-8. [DOI: 10.1016/j.clinre.2017.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
315 Pal A. Copper toxicity induced hepatocerebral and neurodegenerative diseases: an urgent need for prognostic biomarkers. Neurotoxicology 2014;40:97-101. [PMID: 24342654 DOI: 10.1016/j.neuro.2013.12.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
316 Bembenek JP, Kiryluk K, Inglot E, Litwin T, Smoliński Ł, Członkowska A. Blink reflex in newly diagnosed and treated patients with Wilson's disease. J Neural Transm (Vienna) 2021;128:1873-80. [PMID: 34669020 DOI: 10.1007/s00702-021-02432-x] [Reference Citation Analysis]
317 Pitman SK, Huynh T, Bjarnason TA, An J, Malkhasyan KA. A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug. Clin Case Rep 2019;7:990-4. [PMID: 31110732 DOI: 10.1002/ccr3.2125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
318 Langwińska-Wośko E, Litwin T, Szulborski K, Członkowska A. Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease. Metab Brain Dis 2016;31:405-15. [PMID: 26686677 DOI: 10.1007/s11011-015-9776-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
319 Schilsky ML, Roberts EA, Hahn S, Askari F. Costly choices for treating Wilson's disease. Hepatology 2015;61:1106-8. [PMID: 25524500 DOI: 10.1002/hep.27663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
320 Eda K, Mizuochi T, Iwama I, Inui A, Etani Y, Araki M, Hara S, Kumagai H, Hagiwara S, Murayama K, Murakami J, Shimizu N, Kodama H, Yasuda R, Takaki Y, Yamashita Y. Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan: Zinc for pediatric Wilson disease. Journal of Gastroenterology and Hepatology 2018;33:264-9. [DOI: 10.1111/jgh.13812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
321 Poujois A, Trocello JM, Djebrani-Oussedik N, Poupon J, Collet C, Girardot-Tinant N, Sobesky R, Habès D, Debray D, Vanlemmens C, Fluchère F, Ory-Magne F, Labreuche J, Preda C, Woimant F. Exchangeable copper: a reflection of the neurological severity in Wilson's disease. Eur J Neurol 2017;24:154-60. [PMID: 27739240 DOI: 10.1111/ene.13171] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
322 Masełbas W, Członkowska A, Litwin T, Niewada M. Persistence with treatment for Wilson disease: a retrospective study. BMC Neurol 2019;19:278. [PMID: 31718567 DOI: 10.1186/s12883-019-1502-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
323 Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L, Ghidoni R, Koch G, Borroni B, Albanese A, Sensi SL, Rongioletti M. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants. Biomolecules 2021;11:960. [PMID: 34209820 DOI: 10.3390/biom11070960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Despotov K, Klivényi P, Nagy I, Pálvölgyi A, Vécsei L, Rajda C. Rare co-occurrence of multiple sclerosis and Wilson's disease - case report. BMC Neurol 2022;22:178. [PMID: 35578211 DOI: 10.1186/s12883-022-02691-5] [Reference Citation Analysis]
325 Przybyłkowski A, Szeligowska J, Januszewicz M, Raszeja-wyszomirska J, Szczepankiewicz B, Nehring P, Górnicka B, Litwin T, Członkowska A. Evaluation of liver fibrosis in patients with Wilson’s disease. European Journal of Gastroenterology & Hepatology 2021;33:535-40. [DOI: 10.1097/meg.0000000000001754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Medici V, Czlonkowska A, Litwin T, Giulivi C. Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence. Biomolecules 2021;11:1243. [PMID: 34439909 DOI: 10.3390/biom11081243] [Reference Citation Analysis]
327 Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015;14:103-113. [PMID: 25496901 DOI: 10.1016/s1474-4422(14)70190-5] [Cited by in Crossref: 381] [Cited by in F6Publishing: 117] [Article Influence: 54.4] [Reference Citation Analysis]
328 Harada M. Pathogenesis and management of Wilson disease: Wilson disease. Hepatol Res 2014;44:395-402. [DOI: 10.1111/hepr.12301] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
329 Zheng Z, Yu Q, Peng H, Zhang W, Shen Y, Feng H, Huang L, Zhou F, Zhang Q, Wang Q. Research on Portal Venous Hemodynamics and Influencing Factors of Portal Vein System Thrombosis for Wilson’s Disease after Splenectomy. Front Surg 2022;9:834466. [DOI: 10.3389/fsurg.2022.834466] [Reference Citation Analysis]
330 Kaščáková S, Kewish CM, Rouzière S, Schmitt F, Sobesky R, Poupon J, Sandt C, Francou B, Somogyi A, Samuel D, Jacquemin E, Dubart-Kupperschmitt A, Nguyen TH, Bazin D, Duclos-Vallée JC, Guettier C, Le Naour F. Rapid and reliable diagnosis of Wilson disease using X-ray fluorescence. J Pathol Clin Res 2016;2:175-86. [PMID: 27499926 DOI: 10.1002/cjp2.48] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
331 Brunet A, Marotte S, Guillaud O, Lachaux A. Familial screening in Wilson’s disease: Think at the previous generation! Journal of Hepatology 2012;57:1394-5. [DOI: 10.1016/j.jhep.2012.07.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
332 Langwińska-Wośko E, Litwin T, Dzieżyc K, Członkowska A. The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding? Acta Neurol Belg 2016;116:325-8. [PMID: 26577266 DOI: 10.1007/s13760-015-0566-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
333 Garrido I, Marques M, Liberal R, Cardoso H, Lopes S, Macedo G. Wilson disease in Northern Portugal: a long-term follow-up study. Orphanet J Rare Dis 2022;17:82. [PMID: 35197085 DOI: 10.1186/s13023-022-02245-5] [Reference Citation Analysis]
334 Karhan AN, Aykan HH, Gümüş E, Dönmez Y, Alehan D, Özkutlu S, Demir H, Saltık Temizel İN, Özen H, Yüce A. Assessment of cardiac function and electrocardiographic findings in patients with Wilson’s disease. Cardiol Young 2019;29:1183-8. [DOI: 10.1017/s104795111900180x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
335 Mussi MCL, Nardelli MJ, Santos BC, Abreu ES, Osório FMF, Cançado GGL, Ferrari TCA, Faria LC, Couto CA. Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series. Fetal Pediatr Pathol 2021;:1-8. [PMID: 34350816 DOI: 10.1080/15513815.2021.1960940] [Reference Citation Analysis]
336 Mazi TA, Shibata NM, Medici V. Lipid and energy metabolism in Wilson disease. Liver Res 2020;4:5-14. [PMID: 32832193 DOI: 10.1016/j.livres.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
337 Ma K, Berger D, Reau N. Liver Diseases During Pregnancy. Clin Liver Dis 2019;23:345-61. [PMID: 30947881 DOI: 10.1016/j.cld.2018.12.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
338 Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O. A genetic study of Wilson's disease in the United Kingdom. Brain. 2013;136:1476-1487. [PMID: 23518715 DOI: 10.1093/brain/awt035] [Cited by in Crossref: 182] [Cited by in F6Publishing: 152] [Article Influence: 20.2] [Reference Citation Analysis]
339 Gaspar R, Rodrigues S, Silva M, Costa-Moreira P, Morais R, Andrade P, Cardoso H, Albuquerque A, Liberal R, Macedo G. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis 2019;51:1423-9. [PMID: 31113738 DOI: 10.1016/j.dld.2019.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
340 Dzieżyc K, Litwin T, Chabik G, Członkowska A. Frequencies of initial gait disturbances and falls in 100 Wilson's disease patients. Gait & Posture 2015;42:601-3. [DOI: 10.1016/j.gaitpost.2015.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
341 Lv T, Li X, Zhang W, Zhao X, Ou X, Huang J. Recent advance in the molecular genetics of Wilson disease and hereditary hemochromatosis. Eur J Med Genet. 2016;59:532-539. [PMID: 27592149 DOI: 10.1016/j.ejmg.2016.08.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
342 Sandahl TD, Ott P. Epidemiology of Wilson Disease. Wilson Disease. Elsevier; 2019. pp. 85-94. [DOI: 10.1016/b978-0-12-811077-5.00007-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
343 Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11:1028-35.e1-2. [PMID: 23542331 DOI: 10.1016/j.cgh.2013.03.012] [Cited by in Crossref: 108] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
344 Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int 2020;33:925-35. [PMID: 32314442 DOI: 10.1111/tri.13622] [Reference Citation Analysis]
345 Huarte-Muniesa MP, Lacalle-Fabo E, Uriz-Otano J, Berisa-Prado S, Moreno-Laguna S, Burusco-Paternáin MJ. [Complexity of the diagnosis of Wilson disease in clinical practice: our experience in 15 patients]. Gastroenterol Hepatol 2014;37:389-96. [PMID: 24720933 DOI: 10.1016/j.gastrohep.2014.02.007] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
346 Ertan E, Gürvit HI, Hanağası HH, Bilgiç B, Tunçer MA, Yılmaz C. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT®LOUD]) for individuals with Wilson's disease and adult cerebral palsy: two case reports. Logoped Phoniatr Vocol 2021;:1-9. [PMID: 34287100 DOI: 10.1080/14015439.2021.1951348] [Reference Citation Analysis]
347 Oe S, Honma Y, Yabuki K, Morino K, Kumamoto K, Hayashi T, Kusanaga M, Ogino N, Minami S, Shibata M, Abe S, Harada M. Importance of a Liver Biopsy in the Management of Wilson Disease. Intern Med 2020;59:77-81. [PMID: 31511488 DOI: 10.2169/internalmedicine.3440-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
348 Pfeiffenberger J, Kruse C, Mutch P, Harker A, Weiss KH. The steady state pharmacokinetics of trientine in Wilson disease patients. Eur J Clin Pharmacol 2018;74:731-6. [PMID: 29417175 DOI: 10.1007/s00228-018-2424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
349 Thiyagarajan M, Anand K, Dorairajan G, Sagili H, Subbaiah M. Wilson's Disease Diagnosed Postnatally Due to Neurological Manifestation. J Obstet Gynaecol India 2020;70:230-3. [PMID: 32476771 DOI: 10.1007/s13224-019-01270-y] [Reference Citation Analysis]
350 Dzieżyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease. Handb Clin Neurol 2017;142:157-69. [PMID: 28433099 DOI: 10.1016/B978-0-444-63625-6.00013-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
351 Faulkes RE, Chauhan A, Knox E, Johnston T, Thompson F, Ferguson J. Review article: chronic liver disease and pregnancy. Aliment Pharmacol Ther 2020;52:420-9. [PMID: 32598048 DOI: 10.1111/apt.15908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
352 Litwin T, Członkowska A, Socha P. Oral Chelator Treatment of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 357-64. [DOI: 10.1016/b978-0-12-810532-0.00034-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
353 Patell R, Dosi R, Joshi HK, Storz D. Atypical neuroimaging in Wilson's disease. BMJ Case Rep 2014;2014:bcr2013200100. [PMID: 24907221 DOI: 10.1136/bcr-2013-200100] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
354 Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R. Wilson disease — the impact of hyperimmunity on disease activity: A case report. World J Clin Cases 2021; 9(6): 1386-1393 [PMID: 33644206 DOI: 10.12998/wjcc.v9.i6.1386] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Braga CM, Pina IF, Cantilino A, Machado L. Catatonia - not only a schizophrenia subtype: a case report of Wilson's disease. Braz J Psychiatry 2019;41:460-2. [PMID: 31644781 DOI: 10.1590/1516-4446-2019-0558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Cleymaet S, Nagayoshi K, Gettings E, Faden J. A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease. Expert Review of Neurotherapeutics 2019;19:1117-26. [DOI: 10.1080/14737175.2019.1645009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
357 Aggarwal A, Bhatt M. Neurological Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 195-214. [DOI: 10.1016/b978-0-12-810532-0.00018-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Martineau L, Noreau A, Dupré N. Therapies for ataxias. Curr Treat Options Neurol 2014;16:300. [PMID: 24832479 DOI: 10.1007/s11940-014-0300-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
359 Pfister ED. [Wilson's disease : What has been confirmed in diagnostic and therapy?]. Internist (Berl) 2017;58:1233-41. [PMID: 29098318 DOI: 10.1007/s00108-017-0342-9] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
360 Abdel Ghaffar TY, Elsayed SM, El Naghi S, Hamed H, Atta HA. Treatment-induced copper deficiency in two patients with Wilson’s disease: . Egyptian Liver Journal 2016;6:16-20. [DOI: 10.1097/01.elx.0000481903.74931.f7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
361 Weiskirchen S, Kim P, Weiskirchen R. Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry. Ann Transl Med 2019;7:S72. [PMID: 31179309 DOI: 10.21037/atm.2018.10.67] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
362 Ganesh R, Suresh N, Vasanthi T, Sathiyasekaran M, Thulasiraman R. A 6-year-old boy with Wilson disease-A diagnostic dilemma.Indian J Gastroenterol. 2017;36:149-154. [PMID: 28435998 DOI: 10.1007/s12664-017-0746-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
363 Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med 2019;7:S67. [PMID: 31179304 DOI: 10.21037/atm.2019.02.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
364 Woimant F, Djebrani-oussedik N, Collet C, Girardot N, Poujois A. The hidden face of Wilson's disease. Revue Neurologique 2018;174:589-96. [DOI: 10.1016/j.neurol.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
365 Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev 2019;40:59-77. [PMID: 31205375 DOI: 10.33176/AACB-18-00014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
366 Dzieżyc K, Litwin T, Chabik G, Członkowska A. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease. Funct Neurol 2015;30:264-8. [PMID: 26727705 DOI: 10.11138/fneur/2015.30.4.264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
367 Socha P, Janczyk W, Dhawan A, Baumann U, D'Antiga L, Tanner S, Iorio R, Vajro P, Houwen R, Fischler B, Dezsofi A, Hadzic N, Hierro L, Jahnel J, McLin V, Nobili V, Smets F, Verkade HJ, Debray D. Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:334-344. [PMID: 29341979 DOI: 10.1097/mpg.0000000000001787] [Cited by in Crossref: 59] [Cited by in F6Publishing: 13] [Article Influence: 19.7] [Reference Citation Analysis]
368 Vajro P, Ferrante L, Lenta S, Mandato C, Persico M. Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care. Dig Liver Dis 2014;46:295-301. [PMID: 24321359 DOI: 10.1016/j.dld.2013.10.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
369 Litwin T, Bembenek J, Antos A, Przybyłkowski A, Skowrońska M, Kurkowska-Jastrzębska I, Członkowska A. Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review. Acta Neurol Belg 2022;122:505-18. [PMID: 35080708 DOI: 10.1007/s13760-022-01872-w] [Reference Citation Analysis]
370 Sood V, Squires JE, Mazariegos GV, Vockley J, McKiernan PJ. Living Related Liver Transplantation for Metabolic Liver Diseases in Children. J Pediatr Gastroenterol Nutr 2021;72:11-7. [PMID: 32969959 DOI: 10.1097/MPG.0000000000002952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
371 Sartini A, Gitto S, Bianchini M, Verga MC, Di Girolamo M, Bertani A, Del Buono M, Schepis F, Lei B, De Maria N, Villa E. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. Cell Death Dis. 2018;9:87. [PMID: 29367619 DOI: 10.1038/s41419-017-0124-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
372 Karhan AN, Aydemir Y, Demir N, Arslan SS, Gümüş E, Demir H, Özen H, Yüce A, Karaduman AA, Saltık-Temizel İN. Assessment of swallowing function in pediatric patients with Wilson's disease: Results of a videofluoroscopic swallowing study. Arab J Gastroenterol 2021;22:215-9. [PMID: 34538586 DOI: 10.1016/j.ajg.2021.05.013] [Reference Citation Analysis]
373 Ranucci G, Di Dato F, Leone F, Vajro P, Spagnuolo MI, Iorio R. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc? Journal of Pediatric Gastroenterology & Nutrition 2017;64:e72-3. [DOI: 10.1097/mpg.0000000000000613] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
374 Huang L, Yu Q, Peng H. Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy. Med Sci Monit 2021;27:e931157. [PMID: 34120137 DOI: 10.12659/MSM.931157] [Reference Citation Analysis]
375 Taba P. Metals and movement disorders: . Current Opinion in Neurology 2013;26:435-41. [DOI: 10.1097/wco.0b013e3283629beb] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
376 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
377 Zhou XX, Pu XY, Xiao X, Chen DB, Wu C, Li XH, Liang XL. Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years. J Clin Neurosci 2020;81:448-54. [PMID: 33222961 DOI: 10.1016/j.jocn.2020.09.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
378 Liggi M, Murgia D, Civolani A, Demelia E, Sorbello O, Demelia L. The relationship between copper and steatosis in Wilson’s disease. Clin Res Hepatol Gastroenterol. 2013;37:36-40. [PMID: 22572525 DOI: 10.1016/j.clinre.2012.03.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
379 Tan EXX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review. World J Gastroenterol 2020; 26(2): 219-245 [PMID: 31988586 DOI: 10.3748/wjg.v26.i2.219] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
380 Herrine SK, Moayyedi P, Brown RS, Falck-ytter YT. American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease. Gastroenterology 2017;152:648-664.e5. [DOI: 10.1053/j.gastro.2016.12.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
381 Tang S, Bai L, Hou W, Hu Z, Chen X, Zhao J, Liang C, Zhang W, Duan Z, Zheng S. Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta‐Analysis. Front Pharmacol 2022;13:847436. [DOI: 10.3389/fphar.2022.847436] [Reference Citation Analysis]
382 Annamalai AK, Prajna VN, Chowdhury G, Santhi R, Kannan M, Vedantham S, Gurnell M. WILSON'S DISEASE – NEVER TOO LATE. The American Journal of Medicine 2022. [DOI: 10.1016/j.amjmed.2022.04.025] [Reference Citation Analysis]
383 Wang J, Tang L, Xu A, Zhang S, Jiang H, Pei P, Li H, Lv T, Yang Y, Qian N, Naidu K, Yang W. Identification of mutations in the ATP7B gene in 14 Wilson disease children: Case series. Medicine (Baltimore) 2021;100:e25463. [PMID: 33879678 DOI: 10.1097/MD.0000000000025463] [Reference Citation Analysis]
384 Li K, Lindauer C, Haase R, Rüdiger H, Reichmann H, Reuner U, Ziemssen T. Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up. Front Physiol 2017;8:778. [PMID: 29066979 DOI: 10.3389/fphys.2017.00778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
385 Mavis AM, Alonso EM. Liver disease in the adolescent. Clin Liver Dis 2015;19:171-85. [PMID: 25454303 DOI: 10.1016/j.cld.2014.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
386 Doganay S, Gumus K, Koc G, Bayram AK, Dogan MS, Arslan D, Gumus H, Gorkem SB, Ciraci S, Serin HI, Coskun A. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping. Magn Reson Med Sci 2018;17:73-9. [PMID: 28515413 DOI: 10.2463/mrms.mp.2016-0145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
387 Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: 'Copper That Cancer'. Metallomics 2015;7:1459-76. [PMID: 26313539 DOI: 10.1039/c5mt00149h] [Cited by in Crossref: 281] [Cited by in F6Publishing: 88] [Article Influence: 40.1] [Reference Citation Analysis]
388 Ginès P, Graupera I, Lammert F, Angeli P, Caballeria L, Krag A, Guha IN, Murad SD, Castera L. Screening for liver fibrosis in the general population: a call for action. The Lancet Gastroenterology & Hepatology 2016;1:256-60. [DOI: 10.1016/s2468-1253(16)30081-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 10.2] [Reference Citation Analysis]
389 Litwin T, Gromadzka G, Szpak GM, Jabłonka-Salach K, Bulska E, Członkowska A. Brain metal accumulation in Wilson's disease. J Neurol Sci 2013;329:55-8. [PMID: 23597670 DOI: 10.1016/j.jns.2013.03.021] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
390 Aggarwal A, Bhatt M. Advances in Treatment of Wilson Disease. Tremor Other Hyperkinet Mov (N Y) 2018;8:525. [PMID: 29520330 DOI: 10.7916/D841881D] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
391 Yu XE, Gao S, Yang RM, Han YZ. MR Imaging of the Brain in Neurologic Wilson Disease. AJNR Am J Neuroradiol 2019;40:178-83. [PMID: 30635331 DOI: 10.3174/ajnr.A5936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 11.5] [Reference Citation Analysis]
392 Reuner U, Dinger J. Pregnancy and Wilson disease: management and outcome of mother and newborns-experiences of a perinatal centre. Ann Transl Med 2019;7:S56. [PMID: 31179293 DOI: 10.21037/atm.2019.04.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
393 Zhong HJ, Xiao P, Lin D, Zhou HM, He XX. Cirrhosis in Wilson Disease is characterized by Impaired Hepatic Synthesis, Leukopenia and Thrombocytopenia. Int J Med Sci 2020;17:1345-50. [PMID: 32624691 DOI: 10.7150/ijms.44338] [Reference Citation Analysis]
394 Martínez-Morillo E, García-García M, Barneo-Caragol C, Fernández Fernández A, Álvarez FV. Pancytopenia and Peripheral Neuropathy in a Woman with Altered Liver Function Tests. Clin Chem 2019;65:956-60. [PMID: 31358500 DOI: 10.1373/clinchem.2018.298927] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
395 Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151-171. [PMID: 30266282 DOI: 10.1016/j.jhep.2018.09.014] [Cited by in Crossref: 615] [Cited by in F6Publishing: 559] [Article Influence: 153.8] [Reference Citation Analysis]
396 Shimizu N. [Diagnosis and treatment of Wilson disease in Japan]. Rinsho Shinkeigaku 2019;59:565-9. [PMID: 31474637 DOI: 10.5692/clinicalneurol.cn-001241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
397 Hou H, Chen D, Liu J, Feng L, Zhang J, Liang X, Xu Y, Li X. Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy. Front Genet 2022;13:875694. [DOI: 10.3389/fgene.2022.875694] [Reference Citation Analysis]
398 Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29:380-386. [PMID: 24033813 DOI: 10.1111/jgh.12356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
399 Karlas T, Hempel M, Tröltzsch M, Huster D, Günther P, Tenckhoff H, Mössner J, Berg T, Keim V, Wiegand J. Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores. Scand J Gastroenterol. 2012;47:1353-1361. [PMID: 22943453 DOI: 10.3109/00365521.2012.719924] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
400 Borchard S, Raschke S, Zak KM, Eberhagen C, Einer C, Weber E, Müller SM, Michalke B, Lichtmannegger J, Wieser A, Rieder T, Popowicz GM, Adamski J, Klingenspor M, Coles AH, Viana R, Vendelbo MH, Sandahl TD, Schwerdtle T, Plitz T, Zischka H. Bis-choline tetrathiomolybdate prevents copper-induced blood-brain barrier damage. Life Sci Alliance 2022;5:e202101164. [PMID: 34857647 DOI: 10.26508/lsa.202101164] [Reference Citation Analysis]
401 Litwin T, Dzieżyc K, Członkowska A. Wilson disease-treatment perspectives. Ann Transl Med 2019;7:S68. [PMID: 31179305 DOI: 10.21037/atm.2018.12.09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
402 Sipilä JOT, Hietala M, Kytö V, Kaasinen V. Wilson's Disease in Finland: A Nationwide Population-Based Study. Mov Disord 2020;35:2323-7. [PMID: 32618023 DOI: 10.1002/mds.28207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
403 Li H, Liu L, Li Y, He S, Liu Y, Li J, Tao R, Li W, Shang S. Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods. Medicine (Baltimore) 2018;97:e11405. [PMID: 29979436 DOI: 10.1097/MD.0000000000011405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
404 Hassoun J, Hammer N, Magini G, Ponte B, Ongaro M, Rougemont AL, Goossens N, Frossard JL, Spahr L. Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis. Case Reports Hepatol 2021;2021:5583654. [PMID: 34055429 DOI: 10.1155/2021/5583654] [Reference Citation Analysis]
405 Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson's Disease: An Update on the Diagnostic Workup and Management. J Clin Med 2021;10:5097. [PMID: 34768617 DOI: 10.3390/jcm10215097] [Reference Citation Analysis]
406 Li X, Zhang W, Zhou D, Lv T, Xu A, Wang H, Zhao X, Zhang B, Li Y, Jia S, Wang Y, Wang X, Wu Z, Duan W, Wang Q, Nan Y, Shang J, Jiang W, Chen Y, Zheng S, Liu M, Sun L, You H, Jia J, Ou X, Huang J. Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants. Hum Mutat 2019;40:552-65. [PMID: 30702195 DOI: 10.1002/humu.23714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
407 Shribman S, Heller C, Burrows M, Heslegrave A, Swift I, Foiani MS, Gillett GT, Tsochatzis EA, Rowe JB, Gerhard A, Butler CR, Masellis M, Bremner F, Martin A, Jung L, Cook P, Zetterberg H, Bandmann O, Rohrer JD, Warner TT. Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease. Mov Disord 2021;36:503-8. [PMID: 33078859 DOI: 10.1002/mds.28333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
408 Chao D, Pan Y, Gao X. A long-lived Donor–Acceptor fluorescent probe for sequential detection of Cu2+ and biothiols. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020;227:117770. [DOI: 10.1016/j.saa.2019.117770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
409 Ranucci G, Polishchuck R, Iorio R. Wilson’s disease: Prospective developments towards new therapies. World J Gastroenterol 2017; 23(30): 5451-5456 [PMID: 28852304 DOI: 10.3748/wjg.v23.i30.5451] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
410 Gold JI, Gold NB, DeLeon DD, Ganetzky R. Contraceptive use in women with inherited metabolic disorders: a retrospective study and literature review. Orphanet J Rare Dis 2022;17:41. [PMID: 35135572 DOI: 10.1186/s13023-022-02188-x] [Reference Citation Analysis]
411 Lucena-Valera A, Perez-Palacios D, Muñoz-Hernandez R, Romero-Gómez M, Ampuero J. Wilson's disease: Revisiting an old friend. World J Hepatol 2021; 13(6): 634-649 [PMID: 34239699 DOI: 10.4254/wjh.v13.i6.634] [Reference Citation Analysis]
412 Kodama H, Anan Y, Izumi Y, Sato Y, Ogra Y. Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson's disease: a prospective study. BMJ Paediatr Open 2021;5:e000948. [PMID: 34222678 DOI: 10.1136/bmjpo-2020-000948] [Reference Citation Analysis]
413 Zhao T, Fang Z, Tian J, Liu J, Xiao Y, Li H, Chen B. Imaging Kayser-Fleischer Ring in Wilson Disease Using In Vivo Confocal Microscopy. Cornea 2019;38:332-7. [PMID: 30601285 DOI: 10.1097/ICO.0000000000001844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
414 Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: A stepwise approach. World J Gastroenterol 2013; 19(18): 2740-2751 [PMID: 23687411 DOI: 10.3748/wjg.v19.i18.2740] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
415 Huong NTM, Hoa NPA, Ngoc ND, Mai NTP, Yen PH, Anh HTV, Hoa G, Dien TM. Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam. Molecular Genetics and Metabolism Reports 2022;31:100861. [DOI: 10.1016/j.ymgmr.2022.100861] [Reference Citation Analysis]
416 Ala A. Wilson's disease. Medicine 2015;43:661-3. [DOI: 10.1016/j.mpmed.2015.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Janka SS, Bätzing J, Laux G, Holstiege J, Wahler S, Merle U, Mehrabi A, Mohr I, Weiss KH, Mieth M. [Retrospective cross-sectional study based on nationwide data of drug prescriptions and contractional data of outpatient offices regarding Morbus Wilson's disease]. Z Gastroenterol 2020;58:1054-64. [PMID: 33197948 DOI: 10.1055/a-1246-3190] [Reference Citation Analysis]
418 Litwin T, Dušek P, Członkowska A. Symptomatic treatment of neurologic symptoms in Wilson disease. Handb Clin Neurol 2017;142:211-23. [PMID: 28433105 DOI: 10.1016/B978-0-444-63625-6.00018-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
419 Mosca A, Nicita F, Capuano A, Nobili V. Wilson Disease in a Child With Mild Neuropsychiatric and Hepatic Involvement: A Challenging Diagnosis for a Heterogeneous Disorder. J Pediatr Gastroenterol Nutr 2019;69:e118-9. [PMID: 31246682 DOI: 10.1097/MPG.0000000000002433] [Reference Citation Analysis]
420 Mura G, Zimbrean PC, Demelia L, Carta MG. Psychiatric comorbidity in Wilson's disease. Int Rev Psychiatry 2017;29:445-62. [PMID: 28681670 DOI: 10.1080/09540261.2017.1311845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
421 Mohr I, Weiss KH. Current anti-copper therapies in management of Wilson disease. Ann Transl Med 2019;7:S69. [PMID: 31179306 DOI: 10.21037/atm.2019.02.48] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
422 Litwin T, Langwińska-Wośko E, Dzieżyc K, Członkowska A. Sunflower cataract: do not forget Wilson's disease. Pract Neurol 2015;15:385-6. [PMID: 25935927 DOI: 10.1136/practneurol-2014-001056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
423 Rathi S, Dhiman RK. Hepatobiliary Quiz (Answers)-14 (2015). J Clin Exp Hepatol 2015;5:175-8. [PMID: 26155047 DOI: 10.1016/j.jceh.2015.06.007] [Reference Citation Analysis]
424 Abuduxikuer K, Wang JS. Zinc mono-therapy in pre-symptomatic Chinese children with Wilson disease: a single center, retrospective study. PLoS One. 2014;9:e86168. [PMID: 24475083 DOI: 10.1371/journal.pone.0086168] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
425 Kim D, Kim SB, Ryu JL, Hong H, Chang JH, Yoo TJ, Jin X, Park HJ, Han C, Lee BH, Choi JH, Yoo HW, Kim JH, Woo DH. Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy. Cells 2020;9:E872. [PMID: 32252475 DOI: 10.3390/cells9040872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
426 Liu J, Luan J, Zhou X, Cui Y, Han J. Epidemiology, diagnosis, and treatment of Wilson's disease. Intractable Rare Dis Res. 2017;6:249-255. [PMID: 29259852 DOI: 10.5582/irdr.2017.01057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
427 Lin J, Zheng Y, Liu Y, Lin Y, Wang Q, Lin XH, Zhu W, Lin WH, Wang N, Chen WJ, Fu Y. Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients with Neurological Manifestations. Mov Disord 2021;36:1446-50. [PMID: 33502774 DOI: 10.1002/mds.28509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Shribman S, Marjot T, Sharif A, Vimalesvaran S, Ala A, Alexander G, Dhawan A, Dooley J, Gillett GT, Kelly D, Mcneill A, Warner TT, Wheater V, Griffiths W, Bandmann O. Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver. The Lancet Gastroenterology & Hepatology 2022;7:560-75. [DOI: 10.1016/s2468-1253(22)00004-8] [Reference Citation Analysis]
429 Ljubić H, Kalauz M, Telarović S, Ferenci P, Ostojić R, Noli MC, Lepori MB, Hrstić I, Vuković J, Premužić M, Radić D, Ravić KG, Sertić J, Merkler A, Barišić AA, Loudianos G, Vucelić B. ATP7B Gene Mutations in Croatian Patients with Wilson Disease. Genetic Testing and Molecular Biomarkers 2016;20:112-7. [DOI: 10.1089/gtmb.2015.0213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
430 Litwin T, Dusek P, Szafrański T, Dzieżyc K, Członkowska A, Rybakowski JK. Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol 2018;8:199-211. [PMID: 29977520 DOI: 10.1177/2045125318759461] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
431 Plitz T, Boyling L. Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease. Xenobiotica 2019;49:332-8. [DOI: 10.1080/00498254.2018.1443352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
432 Gupta P, Choksi M, Goel A, Zachariah U, Sajith KG, Ramachandran J, Chandy G, Kurian G, Rebekah G, Eapen CE. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting. Indian J Gastroenterol 2018;37:31-8. [PMID: 29457214 DOI: 10.1007/s12664-018-0829-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
433 Adhikari S, Shah PK, Sharma YR. Case Report: Using basic liver function tests as a guide to suspected Wilson’s disease. F1000Res 2021;10:608. [DOI: 10.12688/f1000research.54569.2] [Reference Citation Analysis]
434 Poujois A, Poupon J, Woimant F. Direct Determination of Non-Ceruloplasmin-Bound Copper in Plasma. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 249-55. [DOI: 10.1016/b978-0-12-810532-0.00022-7] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
435 Sridhar MS, Rangaraju A, Anbarasu K, Reddy SP, Daga S, Jayalakshmi S, Shaik B. Evaluation of Kayser-Fleischer ring in Wilson disease by anterior segment optical coherence tomography. Indian J Ophthalmol 2017;65:354-7. [PMID: 28573989 DOI: 10.4103/ijo.IJO_400_16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
436 Tian Y, Gong GZ, Yang X, Peng F. Diagnosis and management of fulminant Wilson's disease: a single center's experience. World J Pediatr. 2016;12:209-214. [PMID: 26041495 DOI: 10.1007/s12519-015-0026-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
437 Pham HP, Schwartz J, Cooling L, Hofmann JC, Kim HC, Morgan S, Pagano MB, Schneiderman J, Winters JL, Yamada C, Wong EC, Wu Y. Report of the ASFA apheresis registry study on Wilson's disease. J Clin Apher. 2016;31:11-15. [PMID: 26275240 DOI: 10.1002/jca.21396] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
438 Seetharaman J, Sarma MS. Chelation therapy in liver diseases of childhood: Current status and response. World J Hepatol 2021; 13(11): 1552-1567 [PMID: 34904029 DOI: 10.4254/wjh.v13.i11.1552] [Reference Citation Analysis]
439 Jernajczyk W, Litwin T, Członkowska A, Bembenek JP. Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson's disease. Acta Neurol Belg 2022;122:745-51. [PMID: 35322347 DOI: 10.1007/s13760-022-01915-2] [Reference Citation Analysis]
440 Devarbhavi H, Reddy VV, Singh R. Wilson Disease Presenting With Acute on Chronic Liver Failure: A Single-Center Experience of Outcome and Predictors of Mortality in 68 Patients. J Clin Exp Hepatol 2019;9:569-73. [PMID: 31695246 DOI: 10.1016/j.jceh.2019.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
441 Jüngst C, Berg T, Cheng J, Green RM, Jia J, Mason AL, Lammert F. Intrahepatic cholestasis in common chronic liver diseases. Eur J Clin Invest. 2013;43:1069-1083. [PMID: 23927644 DOI: 10.1111/eci.12128] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
442 Hashim A, Parnell N. A case of Trientine Overdose. Toxicol Int 2015;22:158-9. [PMID: 26862278 DOI: 10.4103/0971-6580.172262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
443 Kaye OE, Cook P. Determination of a Beckman Coulter AU turbidometric method-specific caeruloplasmin reference interval. Ann Clin Biochem 2021;58:244-6. [PMID: 33412890 DOI: 10.1177/0004563221989360] [Reference Citation Analysis]
444 Usta J, Wehbeh A, Rida K, El-Rifai O, Estiphan TA, Majarian T, Barada K. Phenotype-genotype correlation in Wilson disease in a large Lebanese family: association of c.2299insC with hepatic and of p. Ala1003Thr with neurologic phenotype. PLoS One. 2014;9:e109727. [PMID: 25390358 DOI: 10.1371/journal.pone.0109727] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
445 Li H, Tao R, Liu L, Shang S. Population screening and diagnostic strategies in screening family members of Wilson's disease patients. Ann Transl Med. 2019;7:S59. [PMID: 31179296 DOI: 10.21037/atm.2019.03.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
446 Xu A, Lv T, Zhang B, Zhang W, Ou X, Huang J. Development and evaluation of an unlabeled probe high-resolution melting assay for detection of ATP7B mutations in Wilson's disease. J Clin Lab Anal 2017;31. [PMID: 27638368 DOI: 10.1002/jcla.22064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
447 De Fabregues O, Viñas J, Palasí A, Quintana M, Cardona I, Auger C, Vargas V. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain Behav 2020;10:e01596. [PMID: 32202078 DOI: 10.1002/brb3.1596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
448 Alam S, Khanna R, Sood V, Lal BB, Rawat D. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int 2017;37:1508-14. [PMID: 28111909 DOI: 10.1111/liv.13370] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
449 Appenzeller-Herzog C, Mathes T, Heeres MLS, Weiss KH, Houwen RHJ, Ewald H. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies. Liver Int. 2019;39:2136-2152. [PMID: 31206982 DOI: 10.1111/liv.14179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
450 Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, Gauss A, Stremmel W, Schilsky ML, Ferenci P, Weiss KH. Pregnancy in Wilson's disease: Management and outcome. Hepatology 2018;67:1261-9. [PMID: 28859232 DOI: 10.1002/hep.29490] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
451 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
452 Zhang J, Xiao L, Yang W. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease. BMC Neurol 2020;20:255. [PMID: 32593295 DOI: 10.1186/s12883-020-01827-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
453 Fang WY, Abuduxikuer K, Shi P, Qiu YL, Zhao J, Li YC, Zhang XY, Wang NL, Xie XB, Lu Y, Knisely AS, Wang JS. Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World J Clin Cases 2021; 9(14): 3273-3286 [PMID: 34002136 DOI: 10.12998/wjcc.v9.i14.3273] [Reference Citation Analysis]
454 Pop TL, Grama A, Stefanescu AC, Willheim C, Ferenci P. Acute liver failure with hemolytic anemia in children with Wilson’s disease: Genotype-phenotype correlations? World J Hepatol 2021; 13(10): 1428-1438 [PMID: 34786177 DOI: 10.4254/wjh.v13.i10.1428] [Reference Citation Analysis]
455 Sandahl TD, Gormsen LC, Kjaergaard K, Vendelbo MH, Munk DE, Munk OL, Bender D, Keiding S, Vase KH, Frisch K, Vilstrup H, Ott P. The pathophysiology of Wilson's disease visualized: A human 64 Cu PET study. Hepatology 2022;75:1461-70. [PMID: 34773664 DOI: 10.1002/hep.32238] [Reference Citation Analysis]
456 Schreiner AD, Rockey DC. Evaluation of abnormal liver tests in the adult asymptomatic patient. Current Opinion in Gastroenterology 2018;34:272-9. [DOI: 10.1097/mog.0000000000000447] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
457 Fagiuoli S, Daina E, D'Antiga L, Colledan M, Remuzzi G. Monogenic diseases that can be cured by liver transplantation. J Hepatol. 2013;59:595-612. [PMID: 23578885 DOI: 10.1016/j.jhep.2013.04.004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
458 Stremmel W, Weiskirchen R. Therapeutic strategies in Wilson disease: pathophysiology and mode of action. Annals Trans Med. 2021;. [PMID: 33987430 DOI: 10.21037/atm-20-3090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
459 Kadu P, Sawant B, Kale PP, Prabhavalkar K. Copper-lowering agents as an adjuvant in chemotherapy. Indian J Pharmacol 2021;53:221-5. [PMID: 34169907 DOI: 10.4103/ijp.IJP_68_20] [Reference Citation Analysis]
460 Escudé L, Olivas I, Llach J, Olivas P, Mariño Z, Crespo G. The challenge of diagnosing Wilson's disease in patients with MAFLD. Gastroenterol Hepatol 2021:S0210-5705(21)00225-9. [PMID: 34400193 DOI: 10.1016/j.gastrohep.2021.07.007] [Reference Citation Analysis]
461 Zhang S, Yang W, Li X, Pei P, Dong T, Yang Y, Zhang J. Clinical and genetic characterization of a large cohort of patients with Wilson’s disease in China. Transl Neurodegener 2022;11. [DOI: 10.1186/s40035-022-00287-0] [Reference Citation Analysis]
462 Reeve JL, Frayling IM, Twomey PJ. Challenges in molecular diagnosis of Wilson disease. J Clin Pathol 2020;73:181-2. [PMID: 32060076 DOI: 10.1136/jclinpath-2019-206215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
463 Harada M. Diagnosis for Wilson disease: this disease may not be a rare disease. J Gastroenterol 2021;56:114-5. [PMID: 33392748 DOI: 10.1007/s00535-020-01752-1] [Reference Citation Analysis]
464 Socha P, Tanner S. Wilson’s Disease. In: Guandalini S, Dhawan A, Branski D, editors. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Cham: Springer International Publishing; 2016. pp. 743-52. [DOI: 10.1007/978-3-319-17169-2_65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
465 Weiss KH, Stremmel W. Clinical considerations for an effective medical therapy in Wilson's disease: Treatment efficacy in Wilson disease. Ann N Y Acad Sci 2014;1315:81-5. [DOI: 10.1111/nyas.12437] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
466 Tuschl K, Meyer E, Valdivia LE, Zhao N, Dadswell C, Abdul-Sada A, Hung CY, Simpson MA, Chong WK, Jacques TS, Woltjer RL, Eaton S, Gregory A, Sanford L, Kara E, Houlden H, Cuno SM, Prokisch H, Valletta L, Tiranti V, Younis R, Maher ER, Spencer J, Straatman-Iwanowska A, Gissen P, Selim LA, Pintos-Morell G, Coroleu-Lletget W, Mohammad SS, Yoganathan S, Dale RC, Thomas M, Rihel J, Bodamer OA, Enns CA, Hayflick SJ, Clayton PT, Mills PB, Kurian MA, Wilson SW. Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat Commun 2016;7:11601. [PMID: 27231142 DOI: 10.1038/ncomms11601] [Cited by in Crossref: 143] [Cited by in F6Publishing: 127] [Article Influence: 23.8] [Reference Citation Analysis]
467 Li C, Zhang Z, Zhang P, Liu J. Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review. Hepatol Res. 2014;44:E11-E25. [PMID: 23834468 DOI: 10.1111/hepr.12201] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
468 Kanwar P, Kowdley KV. Metal Storage Disorders. Medical Clinics of North America 2014;98:87-102. [DOI: 10.1016/j.mcna.2013.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
469 Purchase R. The Treatment of Wilson's Disease, a Rare Genetic Disorder of Copper Metabolism. Science Progress 2013;96:19-32. [DOI: 10.3184/003685013x13587771579987] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
470 Członkowska A, Dzieżyc-Jaworska K, Kłysz B, Barbara RO, Litwin T. Difficulties in diagnosis and treatment of Wilson disease-a case series of five patients. Ann Transl Med 2019;7:S73. [PMID: 31179310 DOI: 10.21037/atm.2019.02.37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
471 Ma X, Yang Y, Ma R, Zhang Y, Zou X, Zhu S, Ge X, Yuan Y, Zhang W, Zhu G. Inorganic nanocrystal-dynamic porous polymer assemblies with effective energy transfer for sensitive diagnosis of urine copper. Chem Sci 2020;11:12187-93. [PMID: 34123225 DOI: 10.1039/d0sc04359a] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
472 Peedikayil MC, Al Ashgar HI, Al Mousa A, Al Sebayel M, Al Kahtani K, Alkhail FA. Liver transplantation in Wilson’s disease: Single center experience from Saudi Arabia. World J Hepatol 2013; 5(3): 127-132 [PMID: 23556045 DOI: 10.4254/wjh.v5.i3.127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
473 Sood V, Rawat D, Khanna R, Alam S. Cholestatic liver disease masquerading as Wilson disease. Indian J Gastroenterol 2015;34:174-7. [PMID: 25937485 DOI: 10.1007/s12664-015-0552-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
474 Mainardi V, Rando K, Valverde M, Olivari D, Castelli J, Rey G, Gerona S. Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay. Ann Hepatol. 2019;18:187-192. [PMID: 31113589 DOI: 10.5604/01.3001.0012.7911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
475 Raju K, Bangalore GN, Thuruvekere SN, Pathavanalli VN. Wilson's disease: A Clinical autopsy case report with review of literature. J Nat Sci Biol Med 2015;6:248-52. [PMID: 25810676 DOI: 10.4103/0976-9668.149210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
476 Rupp C, Stremmel W, Weiss K. Novel perspectives on Wilson disease treatment. Wilson Disease. Elsevier; 2017. pp. 225-30. [DOI: 10.1016/b978-0-444-63625-6.00019-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
477 Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Brunet AS, Lachaux A, Bost M. ATP7B variant spectrum in a French pediatric Wilson disease cohort. Eur J Med Genet 2021;64:104305. [PMID: 34400371 DOI: 10.1016/j.ejmg.2021.104305] [Reference Citation Analysis]
478 Camarata MA, Ala A, Schilsky ML. Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations. Hepatol Commun 2019;3:1151-8. [PMID: 31388634 DOI: 10.1002/hep4.1384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]